Motif 962 (n=127)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
B1ANS9 | WDR64 | S886 | ochoa | WD repeat-containing protein 64 | None |
B2RTY4 | MYO9A | S1240 | ochoa | Unconventional myosin-IXa (Unconventional myosin-9a) | Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Regulates Rho by stimulating it's GTPase activity in neurons. Required for the regulation of neurite branching and motor neuron axon guidance (By similarity). {ECO:0000250|UniProtKB:Q8C170, ECO:0000250|UniProtKB:Q9Z1N3}. |
H0YGG7 | None | S22 | ochoa | ADP-ribosylation factor 1 | None |
O00159 | MYO1C | S29 | ochoa | Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) | Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Involved in glucose transporter recycling in response to insulin by regulating movement of intracellular GLUT4-containing vesicles to the plasma membrane. Component of the hair cell's (the sensory cells of the inner ear) adaptation-motor complex. Acts as a mediator of adaptation of mechanoelectrical transduction in stereocilia of vestibular hair cells. Binds phosphoinositides and links the actin cytoskeleton to cellular membranes. {ECO:0000269|PubMed:24636949}.; FUNCTION: [Isoform 3]: Involved in regulation of transcription. Associated with transcriptional active ribosomal genes. Appears to cooperate with the WICH chromatin-remodeling complex to facilitate transcription. Necessary for the formation of the first phosphodiester bond during transcription initiation. {ECO:0000250|UniProtKB:Q9WTI7}. |
O00429 | DNM1L | S40 | psp | Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1) | Functions in mitochondrial and peroxisomal division (PubMed:11514614, PubMed:12499366, PubMed:17301055, PubMed:17460227, PubMed:17553808, PubMed:18695047, PubMed:18838687, PubMed:19342591, PubMed:19411255, PubMed:19638400, PubMed:23283981, PubMed:23530241, PubMed:23921378, PubMed:26992161, PubMed:27145208, PubMed:27145933, PubMed:27301544, PubMed:27328748, PubMed:29478834, PubMed:32439975, PubMed:32484300, PubMed:9570752, PubMed:9786947). Mediates membrane fission through oligomerization into membrane-associated tubular structures that wrap around the scission site to constrict and sever the mitochondrial membrane through a GTP hydrolysis-dependent mechanism (PubMed:23530241, PubMed:23584531, PubMed:33850055). The specific recruitment at scission sites is mediated by membrane receptors like MFF, MIEF1 and MIEF2 for mitochondrial membranes (PubMed:23283981, PubMed:23921378, PubMed:29899447). While the recruitment by the membrane receptors is GTP-dependent, the following hydrolysis of GTP induces the dissociation from the receptors and allows DNM1L filaments to curl into closed rings that are probably sufficient to sever a double membrane (PubMed:29899447). Acts downstream of PINK1 to promote mitochondrial fission in a PRKN-dependent manner (PubMed:32484300). Plays an important role in mitochondrial fission during mitosis (PubMed:19411255, PubMed:26992161, PubMed:27301544, PubMed:27328748). Through its function in mitochondrial division, ensures the survival of at least some types of postmitotic neurons, including Purkinje cells, by suppressing oxidative damage (By similarity). Required for normal brain development, including that of cerebellum (PubMed:17460227, PubMed:26992161, PubMed:27145208, PubMed:27301544, PubMed:27328748). Facilitates developmentally regulated apoptosis during neural tube formation (By similarity). Required for a normal rate of cytochrome c release and caspase activation during apoptosis; this requirement may depend upon the cell type and the physiological apoptotic cues (By similarity). Required for formation of endocytic vesicles (PubMed:20688057, PubMed:23792689, PubMed:9570752). Proposed to regulate synaptic vesicle membrane dynamics through association with BCL2L1 isoform Bcl-X(L) which stimulates its GTPase activity in synaptic vesicles; the function may require its recruitment by MFF to clathrin-containing vesicles (PubMed:17015472, PubMed:23792689). Required for programmed necrosis execution (PubMed:22265414). Rhythmic control of its activity following phosphorylation at Ser-637 is essential for the circadian control of mitochondrial ATP production (PubMed:29478834). {ECO:0000250|UniProtKB:Q8K1M6, ECO:0000269|PubMed:11514614, ECO:0000269|PubMed:12499366, ECO:0000269|PubMed:17015472, ECO:0000269|PubMed:17301055, ECO:0000269|PubMed:17460227, ECO:0000269|PubMed:17553808, ECO:0000269|PubMed:18695047, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19342591, ECO:0000269|PubMed:19411255, ECO:0000269|PubMed:19638400, ECO:0000269|PubMed:20688057, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:23530241, ECO:0000269|PubMed:23584531, ECO:0000269|PubMed:23792689, ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:26992161, ECO:0000269|PubMed:27145208, ECO:0000269|PubMed:27145933, ECO:0000269|PubMed:27301544, ECO:0000269|PubMed:27328748, ECO:0000269|PubMed:29478834, ECO:0000269|PubMed:29899447, ECO:0000269|PubMed:32439975, ECO:0000269|PubMed:32484300, ECO:0000269|PubMed:33850055, ECO:0000269|PubMed:9570752, ECO:0000269|PubMed:9786947}.; FUNCTION: [Isoform 1]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}.; FUNCTION: [Isoform 4]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}. |
O14933 | UBE2L6 | S27 | ochoa | Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein) (RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6) | Catalyzes the covalent attachment of ubiquitin or ISG15 to other proteins. Functions in the E6/E6-AP-induced ubiquitination of p53/TP53. Promotes ubiquitination and subsequent proteasomal degradation of FLT3. {ECO:0000269|PubMed:15131269, ECO:0000269|PubMed:16428300, ECO:0000269|PubMed:20508617}. |
O43900 | PRICKLE3 | S122 | ochoa | Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6) | Involved in the planar cell polarity (PCP) pathway that is essential for the polarization of epithelial cells during morphogenetic processes, including gastrulation and neurulation (By similarity). PCP is maintained by two molecular modules, the global and the core modules, PRICKLE3 being part of the core module (By similarity). Distinct complexes of the core module segregate to opposite sides of the cell, where they interact with the opposite complex in the neighboring cell at or near the adherents junctions (By similarity). Involved in the organization of the basal body (By similarity). Involved in cilia growth and positioning (By similarity). Required for proper assembly, stability, and function of mitochondrial membrane ATP synthase (mitochondrial complex V) (PubMed:32516135). {ECO:0000250|UniProtKB:A8WH69, ECO:0000269|PubMed:32516135}. |
O60318 | MCM3AP | S579 | ochoa | Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (80 kDa MCM3-associated protein) (MCM3 acetylating protein) (MCM3AP) (EC 2.3.1.-) (MCM3 acetyltransferase) | [Isoform GANP]: As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores (PubMed:20005110, PubMed:20384790, PubMed:22307388, PubMed:23591820). Through the acetylation of histones, affects the assembly of nucleosomes at immunoglobulin variable region genes and promotes the recruitment and positioning of transcription complex to favor DNA cytosine deaminase AICDA/AID targeting, hence promoting somatic hypermutations (PubMed:23652018). {ECO:0000269|PubMed:20005110, ECO:0000269|PubMed:20384790, ECO:0000269|PubMed:22307388, ECO:0000269|PubMed:23591820, ECO:0000269|PubMed:23652018}.; FUNCTION: [Isoform MCM3AP]: Binds to and acetylates the replication protein MCM3. Plays a role in the initiation of DNA replication and participates in controls that ensure that DNA replication initiates only once per cell cycle (PubMed:11258703, PubMed:12226073). Through the acetylation of histones, affects the assembly of nucleosomes at immunoglobulin variable region genes and promotes the recruitment and positioning of transcription complex to favor DNA cytosine deaminase AICDA/AID targeting, hence promoting somatic hypermutations (PubMed:23652018). {ECO:0000269|PubMed:11258703, ECO:0000269|PubMed:12226073, ECO:0000269|PubMed:23652018}. |
O60664 | PLIN3 | S175 | ochoa | Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17) | Structural component of lipid droplets, which is required for the formation and maintenance of lipid storage droplets (PubMed:34077757). Required for the transport of mannose 6-phosphate receptors (MPR) from endosomes to the trans-Golgi network (PubMed:9590177). {ECO:0000269|PubMed:34077757, ECO:0000269|PubMed:9590177}. |
O75122 | CLASP2 | S1053 | ochoa|psp | CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2) | Microtubule plus-end tracking protein that promotes the stabilization of dynamic microtubules (PubMed:26003921). Involved in the nucleation of noncentrosomal microtubules originating from the trans-Golgi network (TGN). Required for the polarization of the cytoplasmic microtubule arrays in migrating cells towards the leading edge of the cell. May act at the cell cortex to enhance the frequency of rescue of depolymerizing microtubules by attaching their plus-ends to cortical platforms composed of ERC1 and PHLDB2 (PubMed:16824950). This cortical microtubule stabilizing activity is regulated at least in part by phosphatidylinositol 3-kinase signaling. Also performs a similar stabilizing function at the kinetochore which is essential for the bipolar alignment of chromosomes on the mitotic spindle (PubMed:16866869, PubMed:16914514). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. {ECO:0000269|PubMed:11290329, ECO:0000269|PubMed:15631994, ECO:0000269|PubMed:16824950, ECO:0000269|PubMed:16866869, ECO:0000269|PubMed:16914514, ECO:0000269|PubMed:17543864, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:26003921}. |
O94806 | PRKD3 | S731 | ochoa|psp | Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) | Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress (By similarity). {ECO:0000250}. |
O95155 | UBE4B | S238 | ochoa | Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2) | Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases (By similarity). May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase (By similarity). May regulate myosin assembly in striated muscles together with STUB1 and VCP/p97 by targeting myosin chaperone UNC45B for proteasomal degradation (PubMed:17369820). {ECO:0000250|UniProtKB:P54860, ECO:0000250|UniProtKB:Q9ES00, ECO:0000269|PubMed:17369820}. |
O95400 | CD2BP2 | S151 | ochoa | CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K) | Involved in pre-mRNA splicing as component of the U5 snRNP complex that is involved in spliceosome assembly. {ECO:0000269|PubMed:15840814}. |
O96018 | APBA3 | S46 | ochoa | Amyloid-beta A4 precursor protein-binding family A member 3 (Adapter protein X11gamma) (Neuron-specific X11L2 protein) (Neuronal Munc18-1-interacting protein 3) (Mint-3) | May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta. May enhance the activity of HIF1A in macrophages by inhibiting the activity of HIF1AN. {ECO:0000269|PubMed:19726677}. |
P01258 | CALCA | S43 | ochoa | Calcitonin [Cleaved into: Calcitonin (CT); Katacalcin (Calcitonin carboxyl-terminal peptide) (CCP) (PDN-21)] | [Calcitonin]: Calcitonin is a peptide hormone that causes a rapid but short-lived drop in the level of calcium and phosphate in blood by promoting the incorporation of those ions in the bones. Calcitonin function is mediated by the calcitonin receptor/CALCR and the CALCR-RAMP2 (AMYR2) receptor complex (PubMed:35324283). {ECO:0000269|PubMed:35324283}.; FUNCTION: [Katacalcin]: Katacalcin is a potent plasma calcium-lowering peptide. {ECO:0000269|PubMed:6132180}. |
P04921 | GYPC | S104 | ochoa | Glycophorin-C (Glycoconnectin) (Glycophorin-D) (GPD) (Glycoprotein beta) (PAS-2') (Sialoglycoprotein D) (CD antigen CD236) | This protein is a minor sialoglycoprotein in human erythrocyte membranes. The blood group Gerbich antigens and receptors for Plasmodium falciparum merozoites are most likely located within the extracellular domain. Glycophorin-C plays an important role in regulating the stability of red cells. |
P13639 | EEF2 | S325 | ochoa | Elongation factor 2 (EF-2) (EC 3.6.5.-) | Catalyzes the GTP-dependent ribosomal translocation step during translation elongation (PubMed:26593721). During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively (PubMed:26593721). Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome (PubMed:26593721). {ECO:0000269|PubMed:26593721}. |
P13796 | LCP1 | S418 | ochoa | Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1) | Actin-binding protein (PubMed:16636079, PubMed:17294403, PubMed:28493397). Plays a role in the activation of T-cells in response to costimulation through TCR/CD3 and CD2 or CD28 (PubMed:17294403). Modulates the cell surface expression of IL2RA/CD25 and CD69 (PubMed:17294403). {ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:17294403, ECO:0000269|PubMed:28493397}. |
P13804 | ETFA | S140 | ochoa | Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF) | Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:10356313, PubMed:15159392, PubMed:15975918, PubMed:27499296, PubMed:9334218). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:9334218). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:1430199, PubMed:1882842). {ECO:0000269|PubMed:10356313, ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218, ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}. |
P15923 | TCF3 | S391 | ochoa | Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1) | Transcriptional regulator involved in the initiation of neuronal differentiation and mesenchymal to epithelial transition (By similarity). Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation (By similarity). Together with TCF15, required for the mesenchymal to epithelial transition (By similarity). Dimers bind DNA on E-box motifs: 5'-CANNTG-3' (By similarity). Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer (PubMed:2493990). Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region (By similarity). {ECO:0000250|UniProtKB:P15806, ECO:0000269|PubMed:2493990}.; FUNCTION: [Isoform E47]: Facilitates ATOH7 binding to DNA at the consensus sequence 5'-CAGGTG-3', and positively regulates transcriptional activity. {ECO:0000269|PubMed:31696227}. |
P17174 | GOT1 | S66 | ochoa | Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A) | Biosynthesis of L-glutamate from L-aspartate or L-cysteine (PubMed:21900944). Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. Using L-cysteine as substrate, regulates levels of mercaptopyruvate, an important source of hydrogen sulfide. Mercaptopyruvate is converted into H(2)S via the action of 3-mercaptopyruvate sulfurtransferase (3MST). Hydrogen sulfide is an important synaptic modulator and neuroprotectant in the brain. In addition, catalyzes (2S)-2-aminobutanoate, a by-product in the cysteine biosynthesis pathway (PubMed:27827456). {ECO:0000269|PubMed:16039064, ECO:0000269|PubMed:21900944, ECO:0000269|PubMed:27827456}. |
P18085 | ARF4 | S147 | ochoa | ADP-ribosylation factor 4 | GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus. Part of the ciliary targeting complex containing Rab11, ASAP1, Rabin8/RAB3IP, RAB11FIP3 and ARF4, which direct preciliary vesicle trafficking to mother centriole and ciliogenesis initiation (PubMed:25673879). {ECO:0000269|PubMed:25673879}. |
P19429 | TNNI3 | S42 | psp | Troponin I, cardiac muscle (Cardiac troponin I) | Troponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity. |
P20839 | IMPDH1 | S160 | ochoa | Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I) | Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. |
P22314 | UBA1 | S56 | ochoa | Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1) | Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1447181, PubMed:1606621, PubMed:33108101). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP (PubMed:1447181). Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites (PubMed:22456334). {ECO:0000269|PubMed:1447181, ECO:0000269|PubMed:1606621, ECO:0000269|PubMed:22456334, ECO:0000269|PubMed:33108101}. |
P28347 | TEAD1 | S36 | ochoa | Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) | Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and cooperatively to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription in vivo in a cell-specific manner. The activation function appears to be mediated by a limiting cell-specific transcriptional intermediary factor (TIF). Involved in cardiac development. Binds to the M-CAT motif. {ECO:0000269|PubMed:18579750, ECO:0000269|PubMed:19324877}. |
P31689 | DNAJA1 | S335 | ochoa | DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2) | Co-chaperone for HSPA8/Hsc70 (PubMed:10816573). Stimulates ATP hydrolysis, but not the folding of unfolded proteins mediated by HSPA1A (in vitro) (PubMed:24318877). Plays a role in protein transport into mitochondria via its role as co-chaperone. Functions as a co-chaperone for HSPA1B and negatively regulates the translocation of BAX from the cytosol to mitochondria in response to cellular stress, thereby protecting cells against apoptosis (PubMed:14752510). Promotes apoptosis in response to cellular stress mediated by exposure to anisomycin or UV (PubMed:24512202). {ECO:0000269|PubMed:10816573, ECO:0000269|PubMed:14752510, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24512202, ECO:0000269|PubMed:9192730}. |
P31943 | HNRNPH1 | S104 | ochoa|psp | Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed] | This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation. Inhibits, together with CUGBP1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds poly(RG). {ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:16946708}. |
P32298 | GRK4 | S419 | psp | G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1) | Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2. {ECO:0000269|PubMed:19520868, ECO:0000269|PubMed:8626439}. |
P33981 | TTK | S345 | psp | Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT) | Involved in mitotic spindle assembly checkpoint signaling, a process that delays anaphase until chromosomes are bioriented on the spindle, and in the repair of incorrect mitotic kinetochore-spindle microtubule attachments (PubMed:18243099, PubMed:28441529, PubMed:29162720). Phosphorylates MAD1L1 to promote the mitotic spindle assembly checkpoint (PubMed:18243099, PubMed:29162720). Phosphorylates CDCA8/Borealin leading to enhanced AURKB activity at the kinetochore (PubMed:18243099). Phosphorylates SKA3 at 'Ser-34' leading to dissociation of the SKA complex from microtubules and destabilization of microtubule-kinetochore attachments (PubMed:28441529). Phosphorylates KNL1, KNTC1 and autophosphorylates (PubMed:28441529). Phosphorylates MCRS1 which enhances recruitment of KIF2A to the minus end of spindle microtubules and promotes chromosome alignment (PubMed:30785839). {ECO:0000269|PubMed:18243099, ECO:0000269|PubMed:28441529, ECO:0000269|PubMed:29162720, ECO:0000269|PubMed:30785839}. |
P36402 | TCF7 | S37 | ochoa | Transcription factor 7 (TCF-7) (T-cell-specific transcription factor 1) (T-cell factor 1) (TCF-1) | Transcriptional activator involved in T-cell lymphocyte differentiation. Necessary for the survival of CD4(+) CD8(+) immature thymocytes. Isoforms lacking the N-terminal CTNNB1 binding domain cannot fulfill this role. Binds to the T-lymphocyte-specific enhancer element (5'-WWCAAAG-3') found in the promoter of the CD3E gene. Represses expression of the T-cell receptor gamma gene in alpha-beta T-cell lineages (By similarity). Required for the development of natural killer receptor-positive lymphoid tissue inducer T-cells (By similarity). TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7 and CTNNB1. May also act as feedback transcriptional repressor of CTNNB1 and TCF7L2 target genes. {ECO:0000250|UniProtKB:Q00417}. |
P41240 | CSK | S364 | psp | Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) | Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN, CSK or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK. {ECO:0000269|PubMed:1639064, ECO:0000269|PubMed:9281320}. |
P48751 | SLC4A3 | S1121 | ochoa | Anion exchange protein 3 (AE 3) (Anion exchanger 3) (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3) | Sodium-independent anion exchanger which mediates the electroneutral exchange of chloride for bicarbonate ions across the cell membrane (PubMed:29167417, PubMed:7923606). May be involved in the regulation of intracellular pH, and the modulation of cardiac action potential (PubMed:29167417). {ECO:0000269|PubMed:29167417, ECO:0000269|PubMed:7923606}. |
P49116 | NR2C2 | S55 | ochoa | Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4) | Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear receptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior (By similarity). Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation. {ECO:0000250, ECO:0000269|PubMed:10347174, ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:17974920, ECO:0000269|PubMed:7779113, ECO:0000269|PubMed:9556573}. |
P52597 | HNRNPF | S104 | ochoa | Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed] | Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Plays a role in the regulation of alternative splicing events. Binds G-rich sequences in pre-mRNAs and keeps target RNA in an unfolded state. {ECO:0000269|PubMed:20526337}. |
P55795 | HNRNPH2 | S104 | ochoa|psp | Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed] | This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Binds poly(RG). |
P61204 | ARF3 | S147 | ochoa | ADP-ribosylation factor 3 | GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus. |
P78347 | GTF2I | S19 | ochoa | General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein) | Interacts with the basal transcription machinery by coordinating the formation of a multiprotein complex at the C-FOS promoter, and linking specific signal responsive activator complexes. Promotes the formation of stable high-order complexes of SRF and PHOX1 and interacts cooperatively with PHOX1 to promote serum-inducible transcription of a reporter gene deriven by the C-FOS serum response element (SRE). Acts as a coregulator for USF1 by binding independently two promoter elements, a pyrimidine-rich initiator (Inr) and an upstream E-box. Required for the formation of functional ARID3A DNA-binding complexes and for activation of immunoglobulin heavy-chain transcription upon B-lymphocyte activation. {ECO:0000269|PubMed:10373551, ECO:0000269|PubMed:11373296, ECO:0000269|PubMed:16738337}. |
P84077 | ARF1 | S147 | ochoa | ADP-ribosylation factor 1 (EC 3.6.5.2) | Small GTPase involved in protein trafficking between different compartments (PubMed:8253837). Modulates vesicle budding and uncoating within the Golgi complex (PubMed:8253837). In its GTP-bound form, triggers the recruitment of coatomer proteins to the Golgi membrane (PubMed:8253837). The hydrolysis of ARF1-bound GTP, which is mediated by ARFGAPs proteins, is required for dissociation of coat proteins from Golgi membranes and vesicles (PubMed:8253837). The GTP-bound form interacts with PICK1 to limit PICK1-mediated inhibition of Arp2/3 complex activity; the function is linked to AMPA receptor (AMPAR) trafficking, regulation of synaptic plasticity of excitatory synapses and spine shrinkage during long-term depression (LTD) (By similarity). Plays a key role in the regulation of intestinal stem cells and gut microbiota, and is essential for maintaining intestinal homeostasis (By similarity). Also plays a critical role in mast cell expansion but not in mast cell maturation by facilitating optimal mTORC1 activation (By similarity). {ECO:0000250|UniProtKB:P84079, ECO:0000269|PubMed:8253837}.; FUNCTION: (Microbial infection) Functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. {ECO:0000305}. |
Q05209 | PTPN12 | S449 | ochoa | Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1) | Dephosphorylates a range of proteins, and thereby regulates cellular signaling cascades (PubMed:18559503). Dephosphorylates cellular tyrosine kinases, such as ERBB2 and PTK2B/PYK2, and thereby regulates signaling via ERBB2 and PTK2B/PYK2 (PubMed:17329398, PubMed:27134172). Selectively dephosphorylates ERBB2 phosphorylated at 'Tyr-1112', 'Tyr-1196', and/or 'Tyr-1248' (PubMed:27134172). {ECO:0000269|PubMed:17329398, ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:27134172}. |
Q06830 | PRDX1 | S152 | ochoa | Peroxiredoxin-1 (EC 1.11.1.24) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1) | Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2) (PubMed:9497357). Reduces an intramolecular disulfide bond in GDPD5 that gates the ability to GDPD5 to drive postmitotic motor neuron differentiation (By similarity). {ECO:0000250|UniProtKB:P0CB50, ECO:0000269|PubMed:9497357}. |
Q07157 | TJP1 | S810 | ochoa | Tight junction protein 1 (Tight junction protein ZO-1) (Zona occludens protein 1) (Zonula occludens protein 1) | TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:7798316, PubMed:9792688). Forms a multistranded TJP1/ZO1 condensate which elongates to form a tight junction belt, the belt is anchored at the apical cell membrane via interaction with PATJ (By similarity). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Necessary for lumenogenesis, and particularly efficient epithelial polarization and barrier formation (By similarity). Plays a role in the regulation of cell migration by targeting CDC42BPB to the leading edge of migrating cells (PubMed:21240187). Plays an important role in podosome formation and associated function, thus regulating cell adhesion and matrix remodeling (PubMed:20930113). With TJP2 and TJP3, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). May play a role in mediating cell morphology changes during ameloblast differentiation via its role in tight junctions (By similarity). {ECO:0000250|UniProtKB:O97758, ECO:0000250|UniProtKB:P39447, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:21240187}. |
Q13043 | STK4 | S438 | ochoa|psp | Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] | Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. {ECO:0000250|UniProtKB:Q9JI11, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:11517310, ECO:0000269|PubMed:12757711, ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:17932490, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18986304, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:21212262, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:21512132, ECO:0000269|PubMed:8702870, ECO:0000269|PubMed:8816758}. |
Q13131 | PRKAA1 | S356 | ochoa | 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) | Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed:17307971, PubMed:17712357, PubMed:24563466, PubMed:37821951). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed:17307971, PubMed:17712357). AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators (PubMed:17307971, PubMed:17712357). Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively (By similarity). Promotes lipolysis of lipid droplets by mediating phosphorylation of isoform 1 of CHKA (CHKalpha2) (PubMed:34077757). Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3 (By similarity). AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160 (By similarity). Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A (PubMed:11518699, PubMed:11554766, PubMed:15866171, PubMed:17711846, PubMed:18184930). Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm (By similarity). In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription (By similarity). Acts as a key regulator of cell growth and proliferation by phosphorylating FNIP1, TSC2, RPTOR, WDR24 and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2 (PubMed:14651849, PubMed:18439900, PubMed:20160076, PubMed:21205641). Also phosphorylates and inhibits GATOR2 subunit WDR24 in response to nutrient limitation, leading to suppress glucose-mediated mTORC1 activation (PubMed:36732624). In response to energetic stress, phosphorylates FNIP1, inactivating the non-canonical mTORC1 signaling, thereby promoting nuclear translocation of TFEB and TFE3, and inducing transcription of lysosomal or autophagy genes (PubMed:37079666). In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1 (PubMed:21205641). In that process, it also activates WDR45/WIPI4 (PubMed:28561066). Phosphorylates CASP6, thereby preventing its autoprocessing and subsequent activation (PubMed:32029622). In response to nutrient limitation, phosphorylates transcription factor FOXO3 promoting FOXO3 mitochondrial import (By similarity). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin (PubMed:17486097). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it (By similarity). May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it (By similarity). Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo (By similarity). Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1 (PubMed:12519745, PubMed:20074060). Regulates hepatic lipogenesis. Activated via SIRT3, represses sterol regulatory element-binding protein (SREBP) transcriptional activities and ATP-consuming lipogenesis to restore cellular energy balance. Upon stress, regulates mitochondrial fragmentation through phosphorylation of MTFR1L (PubMed:36367943). {ECO:0000250|UniProtKB:P54645, ECO:0000250|UniProtKB:Q5EG47, ECO:0000269|PubMed:11518699, ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15866171, ECO:0000269|PubMed:17486097, ECO:0000269|PubMed:17711846, ECO:0000269|PubMed:18184930, ECO:0000269|PubMed:18439900, ECO:0000269|PubMed:20074060, ECO:0000269|PubMed:20160076, ECO:0000269|PubMed:21205641, ECO:0000269|PubMed:24563466, ECO:0000269|PubMed:28561066, ECO:0000269|PubMed:32029622, ECO:0000269|PubMed:34077757, ECO:0000269|PubMed:36367943, ECO:0000269|PubMed:36732624, ECO:0000269|PubMed:37079666, ECO:0000269|PubMed:37821951, ECO:0000303|PubMed:17307971, ECO:0000303|PubMed:17712357}. |
Q13405 | MRPL49 | S41 | ochoa | Large ribosomal subunit protein mL49 (39S ribosomal protein L49, mitochondrial) (L49mt) (MRP-L49) (Neighbor of FAU) (NOF) (Protein NOF1) | None |
Q13501 | SQSTM1 | S366 | ochoa|psp | Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) (p62) | Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a bridge between polyubiquitinated proteins and autophagosomes (PubMed:15340068, PubMed:15953362, PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22017874, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:33509017, PubMed:34471133, PubMed:34893540, PubMed:35831301, PubMed:37306101, PubMed:37802024). Promotes the recruitment of ubiquitinated cargo proteins to autophagosomes via multiple domains that bridge proteins and organelles in different steps (PubMed:16286508, PubMed:20168092, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:34893540, PubMed:37802024). SQSTM1 first mediates the assembly and removal of ubiquitinated proteins by undergoing liquid-liquid phase separation upon binding to ubiquitinated proteins via its UBA domain, leading to the formation of insoluble cytoplasmic inclusions, known as p62 bodies (PubMed:15911346, PubMed:20168092, PubMed:22017874, PubMed:24128730, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:37802024). SQSTM1 then interacts with ATG8 family proteins on autophagosomes via its LIR motif, leading to p62 body recruitment to autophagosomes, followed by autophagic clearance of ubiquitinated proteins (PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:37802024). SQSTM1 is itself degraded along with its ubiquitinated cargos (PubMed:16286508, PubMed:17580304, PubMed:37802024). Also required to recruit ubiquitinated proteins to PML bodies in the nucleus (PubMed:20168092). Also involved in autophagy of peroxisomes (pexophagy) in response to reactive oxygen species (ROS) by acting as a bridge between ubiquitinated PEX5 receptor and autophagosomes (PubMed:26344566). Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1: interaction inactivates the BCR(KEAP1) complex by sequestering the complex in inclusion bodies, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes (PubMed:20452972, PubMed:28380357, PubMed:33393215, PubMed:37306101). Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed:29496741). Involved in endosome organization by retaining vesicles in the perinuclear cloud: following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed:27368102, PubMed:33472082). Sequesters tensin TNS2 into cytoplasmic puncta, promoting TNS2 ubiquitination and proteasomal degradation (PubMed:25101860). May regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1 (PubMed:10356400, PubMed:10747026, PubMed:11244088, PubMed:12471037, PubMed:16079148, PubMed:19931284). May play a role in titin/TTN downstream signaling in muscle cells (PubMed:15802564). Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). {ECO:0000250|UniProtKB:Q64337, ECO:0000269|PubMed:10356400, ECO:0000269|PubMed:10747026, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:12471037, ECO:0000269|PubMed:15340068, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:15911346, ECO:0000269|PubMed:15953362, ECO:0000269|PubMed:16079148, ECO:0000269|PubMed:16286508, ECO:0000269|PubMed:17580304, ECO:0000269|PubMed:19931284, ECO:0000269|PubMed:20168092, ECO:0000269|PubMed:20452972, ECO:0000269|PubMed:22017874, ECO:0000269|PubMed:22622177, ECO:0000269|PubMed:24128730, ECO:0000269|PubMed:25101860, ECO:0000269|PubMed:26344566, ECO:0000269|PubMed:27368102, ECO:0000269|PubMed:28380357, ECO:0000269|PubMed:28404643, ECO:0000269|PubMed:29343546, ECO:0000269|PubMed:29496741, ECO:0000269|PubMed:29507397, ECO:0000269|PubMed:31857589, ECO:0000269|PubMed:33393215, ECO:0000269|PubMed:33472082, ECO:0000269|PubMed:33509017, ECO:0000269|PubMed:34471133, ECO:0000269|PubMed:34893540, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:37306101, ECO:0000269|PubMed:37802024}. |
Q13813 | SPTAN1 | S484 | ochoa | Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit) | Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. |
Q14160 | SCRIB | S37 | ochoa | Protein scribble homolog (Scribble) (hScrib) (Protein LAP4) | Scaffold protein involved in different aspects of polarized cell differentiation regulating epithelial and neuronal morphogenesis and T-cell polarization (PubMed:15182672, PubMed:16344308, PubMed:16965391, PubMed:18641685, PubMed:18716323, PubMed:19041750, PubMed:27380321). Via its interaction with CRTAM, required for the late phase polarization of a subset of CD4+ T-cells, which in turn regulates TCR-mediated proliferation and IFNG and IL22 production (By similarity). Plays a role in cell directional movement, cell orientation, cell sheet organization and Golgi complex polarization at the cell migration front (By similarity). Promotes epithelial cell layer barrier function via maintaining cell-cell adhesion (By similarity). Most probably functions in the establishment of apico-basal cell polarity (PubMed:16344308, PubMed:19041750). May function in cell proliferation regulating progression from G1 to S phase and as a positive regulator of apoptosis for instance during acinar morphogenesis of the mammary epithelium (PubMed:16965391, PubMed:19041750). May regulate cell invasion via MAPK-mediated cell migration and adhesion (PubMed:18641685, PubMed:18716323). May play a role in exocytosis and in the targeting of synaptic vesicles to synapses (PubMed:15182672). Functions as an activator of Rac GTPase activity (PubMed:15182672). {ECO:0000250|UniProtKB:A0A8P0N4K0, ECO:0000250|UniProtKB:Q80U72, ECO:0000269|PubMed:15182672, ECO:0000269|PubMed:16344308, ECO:0000269|PubMed:16965391, ECO:0000269|PubMed:18641685, ECO:0000269|PubMed:18716323, ECO:0000269|PubMed:19041750, ECO:0000269|PubMed:27380321}. |
Q14997 | PSME4 | S1614 | ochoa | Proteasome activator complex subunit 4 (Proteasome activator PA200) (Protein BLM10 homolog) (Blm10) (hBlm10) | Associated component of the proteasome that specifically recognizes acetylated histones and promotes ATP- and ubiquitin-independent degradation of core histones during spermatogenesis and DNA damage response. Recognizes and binds acetylated histones via its bromodomain-like (BRDL) region and activates the proteasome by opening the gated channel for substrate entry. Binds to the core proteasome via its C-terminus, which occupies the same binding sites as the proteasomal ATPases, opening the closed structure of the proteasome via an active gating mechanism. Component of the spermatoproteasome, a form of the proteasome specifically found in testis: binds to acetylated histones and promotes degradation of histones, thereby participating actively to the exchange of histones during spermatogenesis. Also involved in DNA damage response in somatic cells, by promoting degradation of histones following DNA double-strand breaks. {ECO:0000269|PubMed:12093752, ECO:0000269|PubMed:18845680, ECO:0000269|PubMed:22550082, ECO:0000269|PubMed:23706739}. |
Q15051 | IQCB1 | S572 | ochoa | IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein) (PIQ) | Involved in ciliogenesis. The function in an early step in cilia formation depends on its association with CEP290/NPHP6 (PubMed:21565611, PubMed:23446637). Involved in regulation of the BBSome complex integrity, specifically for presence of BBS2 and BBS5 in the complex, and in ciliary targeting of selected BBSome cargos. May play a role in controlling entry of the BBSome complex to cilia possibly implicating CEP290/NPHP6 (PubMed:25552655). {ECO:0000269|PubMed:23446637, ECO:0000269|PubMed:25552655}. |
Q15139 | PRKD1 | S738 | ochoa|psp | Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) | Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response (PubMed:10764790, PubMed:12505989, PubMed:12637538, PubMed:17442957, PubMed:18509061, PubMed:19135240, PubMed:19211839). Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation (PubMed:10523301). Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-463 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1 (PubMed:12505989). Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenetic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2 (PubMed:18509061). In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling (PubMed:18332134). Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation (PubMed:19211839). In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents (PubMed:10764790). In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines (PubMed:17442957). Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 (By similarity). May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor (PubMed:15471852). Plays a role in activated KRAS-mediated stabilization of ZNF304 in colorectal cancer (CRC) cells (PubMed:24623306). Regulates nuclear translocation of transcription factor TFEB in macrophages upon live S.enterica infection (By similarity). {ECO:0000250|UniProtKB:Q62101, ECO:0000269|PubMed:10523301, ECO:0000269|PubMed:10764790, ECO:0000269|PubMed:12505989, ECO:0000269|PubMed:12637538, ECO:0000269|PubMed:15471852, ECO:0000269|PubMed:17442957, ECO:0000269|PubMed:18332134, ECO:0000269|PubMed:18509061, ECO:0000269|PubMed:19135240, ECO:0000269|PubMed:19211839, ECO:0000269|PubMed:24623306}. |
Q2M2I8 | AAK1 | S797 | ochoa | AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) | Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:17494869, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residues (PubMed:11877457, PubMed:18657069). Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes (PubMed:12952931). Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes (PubMed:18657069). Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity (PubMed:21464124). {ECO:0000269|PubMed:11877457, ECO:0000269|PubMed:11877461, ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:14617351, ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124, ECO:0000269|PubMed:25653444}.; FUNCTION: (Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue. {ECO:0000269|PubMed:25653444, ECO:0000305|PubMed:31136173}. |
Q5BKX8 | CAVIN4 | S346 | ochoa | Caveolae-associated protein 4 (Muscle-related coiled-coil protein) (Muscle-restricted coiled-coil protein) | Modulates the morphology of formed caveolae in cardiomyocytes, but is not required for caveolar formation. Facilitates the recruitment of MAPK1/3 to caveolae within cardiomyocytes and regulates alpha-1 adrenergic receptor-induced hypertrophic responses in cardiomyocytes through MAPK1/3 activation. Contributes to proper membrane localization and stabilization of caveolin-3 (CAV3) in cardiomyocytes (By similarity). Induces RHOA activation and activates NPPA transcription and myofibrillar organization through the Rho/ROCK signaling pathway (PubMed:18332105). {ECO:0000250|UniProtKB:A2AMM0, ECO:0000269|PubMed:18332105}. |
Q5H9R7 | PPP6R3 | S579 | ochoa | Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) | Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. May have an important role in maintaining immune self-tolerance. {ECO:0000269|PubMed:11401438, ECO:0000269|PubMed:16769727}. |
Q5JSH3 | WDR44 | S871 | ochoa | WD repeat-containing protein 44 (Rab11-binding protein) (Rab11BP) (Rabphilin-11) | Downstream effector for Rab11 which regulates Rab11 intracellular membrane trafficking functions such as endocytic recycling, intracellular ciliogenesis and protein export (PubMed:31204173, PubMed:32344433). ATK1-mediated phosphorylation of WDR44 induces binding to Rab11 which activates endocytic recycling of transferrin receptor back to the plasma membrane (PubMed:31204173). When bound to Rab11, prevents the formation of the ciliogenic Rab11-Rabin8/RAB3IP-RAB11FIP3 complex, therefore inhibiting preciliary trafficking and ciliogenesis (PubMed:31204173). Participates in neo-synthesized protein export by connecting the endoplasmic reticulum (ER) with the endosomal tubule via direct interactions with the integral ER proteins VAPA or VAPB and the endosomal protein GRAFs (GRAF1/ARHGAP26 or GRAF2/ARHGAP10), which facilitates the transfer of proteins such as E-cadherin, MPP14 and CFTR into a Rab8-Rab10-Rab11-dependent export route (PubMed:32344433). {ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:32344433}. |
Q5JUK3 | KCNT1 | S407 | psp | Potassium channel subfamily T member 1 (KCa4.1) (KNa1.1) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.2) | Sodium-activated K(+) channel (PubMed:37494189). Acts as an important mediator of neuronal membrane excitability (PubMed:37494189). Contributes to the delayed outward currents (By similarity). Regulates neuronal bursting in sensory neurons (By similarity). Contributes to synaptic development and plasticity (By similarity). {ECO:0000250|UniProtKB:Q6ZPR4, ECO:0000250|UniProtKB:Q9Z258, ECO:0000269|PubMed:37494189}. |
Q5SQS7 | SH2D4B | S361 | ochoa | SH2 domain-containing protein 4B | None |
Q5SSJ5 | HP1BP3 | S377 | ochoa | Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74) | Component of heterochromatin that maintains heterochromatin integrity during G1/S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity (PubMed:24830416). Mediates chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance and self-renewal (PubMed:25100860). {ECO:0000269|PubMed:24830416, ECO:0000269|PubMed:25100860}. |
Q5SXM2 | SNAPC4 | S68 | ochoa | snRNA-activating protein complex subunit 4 (SNAPc subunit 4) (Proximal sequence element-binding transcription factor subunit alpha) (PSE-binding factor subunit alpha) (PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit) (SNAPc 190 kDa subunit) | Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. {ECO:0000269|PubMed:12621023, ECO:0000269|PubMed:9418884}. |
Q5SXM2 | SNAPC4 | S1400 | ochoa | snRNA-activating protein complex subunit 4 (SNAPc subunit 4) (Proximal sequence element-binding transcription factor subunit alpha) (PSE-binding factor subunit alpha) (PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit) (SNAPc 190 kDa subunit) | Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. {ECO:0000269|PubMed:12621023, ECO:0000269|PubMed:9418884}. |
Q5T5X7 | BEND3 | S54 | ochoa | BEN domain-containing protein 3 | Transcriptional repressor which associates with the NoRC (nucleolar remodeling complex) complex and plays a key role in repressing rDNA transcription. The sumoylated form modulates the stability of the NoRC complex component BAZ2A/TIP5 by controlling its USP21-mediated deubiquitination (PubMed:21914818, PubMed:26100909). Binds to unmethylated major satellite DNA and is involved in the recruitment of the Polycomb repressive complex 2 (PRC2) to major satellites (By similarity). Stimulates the ERCC6L translocase and ATPase activities (PubMed:28977671). {ECO:0000250|UniProtKB:Q6PAL0, ECO:0000269|PubMed:21914818, ECO:0000269|PubMed:26100909, ECO:0000269|PubMed:28977671}. |
Q5VTT5 | MYOM3 | S240 | ochoa | Myomesin-3 (Myomesin family member 3) | May link the intermediate filament cytoskeleton to the M-disk of the myofibrils in striated muscle. {ECO:0000250}. |
Q684P5 | RAP1GAP2 | S34 | ochoa | Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4) | GTPase activator for the nuclear Ras-related regulatory protein RAP-1A (KREV-1), converting it to the putatively inactive GDP-bound state. {ECO:0000269|PubMed:15632203}. |
Q6NXG1 | ESRP1 | S74 | ochoa | Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A) | mRNA splicing factor that regulates the formation of epithelial cell-specific isoforms. Specifically regulates the expression of FGFR2-IIIb, an epithelial cell-specific isoform of FGFR2. Also regulates the splicing of CD44, CTNND1, ENAH, 3 transcripts that undergo changes in splicing during the epithelial-to-mesenchymal transition (EMT). Acts by directly binding specific sequences in mRNAs. Binds the GU-rich sequence motifs in the ISE/ISS-3, a cis-element regulatory region present in the mRNA of FGFR2 (PubMed:19285943). Regulates splicing and expression of genes involved in inner ear development, auditory hair cell differentiation, and cell fate specification in the cochlear epithelium (By similarity). {ECO:0000250|UniProtKB:Q3US41, ECO:0000269|PubMed:19285943}. |
Q6NXT6 | TAPT1 | S542 | ochoa | Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor) | Plays a role in primary cilia formation (PubMed:26365339). May act as a downstream effector of HOXC8 possibly by transducing or transmitting extracellular information required for axial skeletal patterning during development (By similarity). May be involved in cartilage and bone development (By similarity). May play a role in the differentiation of cranial neural crest cells (By similarity). {ECO:0000250|UniProtKB:A2BIE7, ECO:0000250|UniProtKB:Q4VBD2, ECO:0000269|PubMed:26365339}.; FUNCTION: (Microbial infection) In case of infection, may act as a fusion receptor for cytomegalovirus (HCMV) strain AD169. {ECO:0000269|PubMed:10640539}. |
Q6P9B6 | MEAK7 | S425 | ochoa | MTOR-associated protein MEAK7 (MEAK7) (MTOR associated protein, eak-7 homolog) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1) | Activates an alternative mTOR signaling through RPS6KB2 activation and EIF4EBP1 repression to regulate cell proliferation and migration (PubMed:29750193). Recruits MTOR at the lysosome, essential for MTOR signaling at the lysosome (PubMed:29750193). {ECO:0000269|PubMed:29750193}. |
Q7L4P6 | BEND5 | S53 | ochoa | BEN domain-containing protein 5 | Acts as a transcriptional repressor (PubMed:23468431). {ECO:0000269|PubMed:23468431}. |
Q7Z3G6 | PRICKLE2 | S66 | ochoa | Prickle-like protein 2 | None |
Q86VF7 | NRAP | S1482 | ochoa | Nebulin-related-anchoring protein (N-RAP) | May be involved in anchoring the terminal actin filaments in the myofibril to the membrane and in transmitting tension from the myofibrils to the extracellular matrix. {ECO:0000250|UniProtKB:Q80XB4}. |
Q86VR2 | RETREG3 | S373 | ochoa | Reticulophagy regulator 3 | Endoplasmic reticulum (ER)-anchored autophagy regulator which exists in an inactive state under basal conditions but is activated following cellular stress (PubMed:34338405). When activated, induces ER fragmentation and mediates ER delivery into lysosomes through sequestration into autophagosomes via interaction with ATG8 family proteins (PubMed:34338405). Promotes ER membrane curvature and ER tubulation required for subsequent ER fragmentation and engulfment into autophagosomes (PubMed:33826365). Required for collagen quality control in a LIR motif-dependent manner (By similarity). Mediates NRF1-enhanced neurite outgrowth (PubMed:26040720). {ECO:0000250|UniProtKB:Q9CQV4, ECO:0000269|PubMed:26040720, ECO:0000269|PubMed:33826365, ECO:0000269|PubMed:34338405}. |
Q86YS6 | RAB43 | S193 | ochoa | Ras-related protein Rab-43 (Ras-related protein Rab-41) | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. The low intrinsic GTPase activity of RAB43 is activated by USP6NL. Involved in retrograde transport from the endocytic pathway to the Golgi apparatus. Involved in the transport of Shiga toxin from early and recycling endosomes to the trans-Golgi network. Required for the structural integrity of the Golgi complex. Plays a role in the maturation of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis. {ECO:0000269|PubMed:17562788, ECO:0000269|PubMed:17684057, ECO:0000269|PubMed:18664496, ECO:0000269|PubMed:21255211}. |
Q86Z02 | HIPK1 | S38 | ochoa | Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) | Serine/threonine-protein kinase involved in transcription regulation and TNF-mediated cellular apoptosis. Plays a role as a corepressor for homeodomain transcription factors. Phosphorylates DAXX and MYB. Phosphorylates DAXX in response to stress, and mediates its translocation from the nucleus to the cytoplasm. Inactivates MYB transcription factor activity by phosphorylation. Prevents MAP3K5-JNK activation in the absence of TNF. TNF triggers its translocation to the cytoplasm in response to stress stimuli, thus activating nuclear MAP3K5-JNK by derepression and promoting apoptosis. May be involved in anti-oxidative stress responses. Involved in the regulation of eye size, lens formation and retinal lamination during late embryogenesis. Promotes angiogenesis and to be involved in erythroid differentiation. May be involved in malignant squamous cell tumor formation. Phosphorylates PAGE4 at 'Thr-51' which is critical for the ability of PAGE4 to potentiate the transcriptional activator activity of JUN (PubMed:24559171). {ECO:0000269|PubMed:12702766, ECO:0000269|PubMed:12968034, ECO:0000269|PubMed:15701637, ECO:0000269|PubMed:16390825, ECO:0000269|PubMed:19646965, ECO:0000269|PubMed:24559171}. |
Q8IX12 | CCAR1 | S994 | ochoa | Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain) | Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation (PubMed:12816952). In association with CALCOCO1 enhances GATA1- and MED1-mediated transcriptional activation from the gamma-globin promoter during erythroid differentiation of K562 erythroleukemia cells (PubMed:24245781). Can act as a both a coactivator and corepressor of AR-mediated transcription. Contributes to chromatin looping and AR transcription complex assembly by stabilizing AR-GATA2 association on chromatin and facilitating MED1 and RNA polymerase II recruitment to AR-binding sites. May play an important role in the growth and tumorigenesis of prostate cancer cells (PubMed:23887938). {ECO:0000250|UniProtKB:Q8CH18, ECO:0000269|PubMed:12816952, ECO:0000269|PubMed:23887938, ECO:0000269|PubMed:24245781}. |
Q8N3D4 | EHBP1L1 | S1123 | ochoa | EH domain-binding protein 1-like protein 1 | May act as Rab effector protein and play a role in vesicle trafficking. {ECO:0000305|PubMed:27552051}. |
Q8NFJ5 | GPRC5A | S59 | ochoa | Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1) | Orphan receptor. Could be involved in modulating differentiation and maintaining homeostasis of epithelial cells. This retinoic acid-inducible GPCR provide evidence for a possible interaction between retinoid and G-protein signaling pathways. Functions as a negative modulator of EGFR signaling (By similarity). May act as a lung tumor suppressor (PubMed:18000218). {ECO:0000250|UniProtKB:Q8BHL4, ECO:0000269|PubMed:18000218}. |
Q8NFU5 | IPMK | S348 | ochoa | Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase) | Inositol phosphate kinase with a broad substrate specificity (PubMed:12027805, PubMed:12223481, PubMed:28882892, PubMed:30420721, PubMed:30624931). Phosphorylates inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) first to inositol 1,3,4,5-tetrakisphosphate and then to inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) (PubMed:12027805, PubMed:12223481, PubMed:28882892, PubMed:30624931). Phosphorylates inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4) (PubMed:12223481). Phosphorylates inositol 1,4,5,6-tetrakisphosphate (Ins(1,4,5,6)P4) (By similarity). Phosphorylates glycero-3-phospho-1D-myo-inositol 4,5-bisphosphate to glycero-3-phospho-1D-myo-inositol 3,4,5-trisphosphate (PubMed:28882892, PubMed:30420721). Plays an important role in MLKL-mediated necroptosis via its role in the biosynthesis of inositol pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6). Binding of these highly phosphorylated inositol phosphates to MLKL mediates the release of an N-terminal auto-inhibitory region, leading to activation of the kinase. Essential for activated phospho-MLKL to oligomerize and localize to the cell membrane during necroptosis (PubMed:29883610). Required for normal embryonic development, probably via its role in the biosynthesis of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) and inositol hexakisphosphate (InsP6) (By similarity). {ECO:0000250|UniProtKB:Q7TT16, ECO:0000269|PubMed:12027805, ECO:0000269|PubMed:12223481, ECO:0000269|PubMed:28882892, ECO:0000269|PubMed:29883610, ECO:0000269|PubMed:30420721, ECO:0000269|PubMed:30624931}. |
Q8NI35 | PATJ | S645 | ochoa | InaD-like protein (Inadl protein) (hINADL) (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions) | Scaffolding protein that facilitates the localization of proteins to the cell membrane (PubMed:11927608, PubMed:16678097, PubMed:22006950). Required for the correct formation of tight junctions and epithelial apico-basal polarity (PubMed:11927608, PubMed:16678097). Acts (via its L27 domain) as an apical connector and elongation factor for multistranded TJP1/ZO1 condensates that form a tight junction belt, thereby required for the formation of the tight junction-mediated cell barrier (By similarity). Positively regulates epithelial cell microtubule elongation and cell migration, possibly via facilitating localization of PRKCI/aPKC and PAR3D/PAR3 at the leading edge of migrating cells (By similarity). Plays a role in the correct reorientation of the microtubule-organizing center during epithelial migration (By similarity). May regulate the surface expression and/or function of ASIC3 in sensory neurons (By similarity). May recruit ARHGEF18 to apical cell-cell boundaries (PubMed:22006950). {ECO:0000250|UniProtKB:E2QYC9, ECO:0000250|UniProtKB:Q63ZW7, ECO:0000269|PubMed:11927608, ECO:0000269|PubMed:16678097, ECO:0000269|PubMed:22006950}. |
Q8TEW0 | PARD3 | S852 | ochoa | Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha) | Adapter protein involved in asymmetrical cell division and cell polarization processes (PubMed:10954424, PubMed:27925688). Seems to play a central role in the formation of epithelial tight junctions (PubMed:27925688). Targets the phosphatase PTEN to cell junctions (By similarity). Involved in Schwann cell peripheral myelination (By similarity). Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly (By similarity). The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins (PubMed:10934474). Required for establishment of neuronal polarity and normal axon formation in cultured hippocampal neurons (PubMed:19812038, PubMed:27925688). {ECO:0000250|UniProtKB:Q99NH2, ECO:0000250|UniProtKB:Q9Z340, ECO:0000269|PubMed:10934474, ECO:0000269|PubMed:10954424, ECO:0000269|PubMed:19812038, ECO:0000269|PubMed:27925688}. |
Q8TF05 | PPP4R1 | S442 | ochoa | Serine/threonine-protein phosphatase 4 regulatory subunit 1 | Regulatory subunit of serine/threonine-protein phosphatase 4. May play a role in regulation of cell division in renal glomeruli. The PPP4C-PPP4R1 PP4 complex may play a role in dephosphorylation and regulation of HDAC3. Plays a role in the inhibition of TNF-induced NF-kappa-B activation by regulating the dephosphorylation of TRAF2. {ECO:0000269|PubMed:15805470}.; FUNCTION: (Microbial infection) Participates in merkel polyomavirus-mediated inhibition of NF-kappa-B by bridging viral small tumor antigen with NEMO. {ECO:0000269|PubMed:28445980}. |
Q8WZ75 | ROBO4 | S564 | ochoa | Roundabout homolog 4 (Magic roundabout) | Receptor for Slit proteins, at least for SLIT2, and seems to be involved in angiogenesis and vascular patterning. May mediate the inhibition of primary endothelial cell migration by Slit proteins (By similarity). Involved in the maintenance of endothelial barrier organization and function (PubMed:30455415). {ECO:0000250, ECO:0000269|PubMed:30455415}. |
Q92556 | ELMO1 | S580 | ochoa | Engulfment and cell motility protein 1 (Protein ced-12 homolog) | Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Acts in association with DOCK1 and CRK. Was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. May enhance the guanine nucleotide exchange factor (GEF) activity of DOCK1. {ECO:0000269|PubMed:11595183, ECO:0000269|PubMed:12134158}. |
Q92835 | INPP5D | S170 | ochoa | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (EC 3.1.3.86) (Inositol polyphosphate-5-phosphatase D) (EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa) (SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1) (SH2 domain-containing inositol phosphatase 1) (SHIP-1) (p150Ship) (hp51CN) | Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways (PubMed:10764818, PubMed:8723348, PubMed:8769125). Able also to hydrolyzes the 5-phosphate of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P3) and inositol 1,3,4,5-tetrakisphosphate (PubMed:10764818, PubMed:8769125, PubMed:9108392). Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity (PubMed:16682172). Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. {ECO:0000269|PubMed:10764818, ECO:0000269|PubMed:12421919, ECO:0000269|PubMed:16682172, ECO:0000269|PubMed:8723348, ECO:0000269|PubMed:8769125, ECO:0000269|PubMed:9108392}. |
Q96BY6 | DOCK10 | S302 | ochoa | Dedicator of cytokinesis protein 10 (Zizimin-3) | Guanine nucleotide-exchange factor (GEF) that activates CDC42 and RAC1 by exchanging bound GDP for free GTP. Essential for dendritic spine morphogenesis in Purkinje cells and in hippocampal neurons, via a CDC42-mediated pathway. Sustains B-cell lymphopoiesis in secondary lymphoid tissues and regulates FCER2/CD23 expression. {ECO:0000250|UniProtKB:Q8BZN6}. |
Q96CT7 | CCDC124 | S194 | ochoa | Coiled-coil domain-containing protein 124 | Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage (PubMed:32687489). Also required for proper progression of late cytokinetic stages (PubMed:23894443). {ECO:0000269|PubMed:23894443, ECO:0000269|PubMed:32687489}. |
Q96IT1 | ZNF496 | S188 | ochoa | Zinc finger protein 496 (Zinc finger protein with KRAB and SCAN domains 17) | DNA-binding transcription factor that can both act as an activator and a repressor. {ECO:0000250}. |
Q96MT3 | PRICKLE1 | S62 | ochoa | Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1) | Involved in the planar cell polarity pathway that controls convergent extension during gastrulation and neural tube closure. Convergent extension is a complex morphogenetic process during which cells elongate, move mediolaterally, and intercalate between neighboring cells, leading to convergence toward the mediolateral axis and extension along the anteroposterior axis. Necessary for nuclear localization of REST. May serve as nuclear receptor. {ECO:0000269|PubMed:21901791}. |
Q96PK6 | RBM14 | S627 | ochoa | RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein) | Isoform 1 may function as a nuclear receptor coactivator, enhancing transcription through other coactivators such as NCOA6 and CITED1. Isoform 2, functions as a transcriptional repressor, modulating transcriptional activities of coactivators including isoform 1, NCOA6 and CITED1 (PubMed:11443112). Regulates centriole biogenesis by suppressing the formation of aberrant centriolar protein complexes in the cytoplasm and thus preserving mitotic spindle integrity. Prevents the formation of the STIL-CPAP complex (which can induce the formation of aberrant centriolar protein complexes) by interfering with the interaction of STIL with CPAP (PubMed:25385835). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also involved in the regulation of pre-mRNA alternative splicing (PubMed:37548402). {ECO:0000269|PubMed:11443112, ECO:0000269|PubMed:25385835, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:37548402}. |
Q96Q07 | BTBD9 | S577 | ochoa | BTB/POZ domain-containing protein 9 | None |
Q96QB1 | DLC1 | S1296 | ochoa | Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein) (DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12) | Functions as a GTPase-activating protein for the small GTPases RHOA, RHOB, RHOC and CDC42, terminating their downstream signaling. This induces morphological changes and detachment through cytoskeletal reorganization, playing a critical role in biological processes such as cell migration and proliferation. Also functions in vivo as an activator of the phospholipase PLCD1. Active DLC1 increases cell migration velocity but reduces directionality. Required for growth factor-induced epithelial cell migration; in resting cells, interacts with TNS3 while PTEN interacts with the p85 regulatory subunit of the PI3K kinase complex but growth factor stimulation induces phosphorylation of TNS3 and PTEN, causing them to change their binding preference so that PTEN interacts with DLC1 and TNS3 interacts with p85 (PubMed:26166433). The PTEN-DLC1 complex translocates to the posterior of migrating cells to activate RHOA while the TNS3-p85 complex translocates to the leading edge of migrating cells to promote RAC1 activation (PubMed:26166433). {ECO:0000269|PubMed:18786931, ECO:0000269|PubMed:19170769, ECO:0000269|PubMed:19710422, ECO:0000269|PubMed:26166433}. |
Q99459 | CDC5L | S358 | ochoa|psp | Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein) | DNA-binding protein involved in cell cycle control. May act as a transcription activator. Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (PubMed:11991638, PubMed:20176811, PubMed:28076346, PubMed:28502770, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30705154, PubMed:30728453). Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR) (PubMed:20176811). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:10570151, ECO:0000269|PubMed:11082045, ECO:0000269|PubMed:11101529, ECO:0000269|PubMed:11544257, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12927788, ECO:0000269|PubMed:18583928, ECO:0000269|PubMed:20176811, ECO:0000269|PubMed:24332808, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:30728453, ECO:0000269|PubMed:9038199, ECO:0000269|PubMed:9468527, ECO:0000269|PubMed:9632794, ECO:0000305|PubMed:33509932}. |
Q9BTT6 | LRRC1 | S37 | ochoa | Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein) | None |
Q9BXM7 | PINK1 | S402 | psp | Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1) | Serine/threonine-protein kinase which acts as a sensor of mitochondrial damage and protects against mitochondrial dysfunction during cellular stress. It phosphorylates mitochondrial proteins to coordinate mitochondrial quality control mechanisms that remove and replace dysfunctional mitochondrial components (PubMed:14607334, PubMed:15087508, PubMed:18443288, PubMed:18957282, PubMed:19229105, PubMed:19966284, PubMed:20404107, PubMed:20547144, PubMed:20798600, PubMed:22396657, PubMed:23620051, PubMed:23754282, PubMed:23933751, PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:24896179, PubMed:24898855, PubMed:25527291, PubMed:32484300). Depending on the severity of mitochondrial damage, activity ranges from preventing apoptosis and stimulating mitochondrial biogenesis to eliminating severely damaged mitochondria via PINK1-PRKN-dependent mitophagy (PubMed:14607334, PubMed:15087508, PubMed:18443288, PubMed:19966284, PubMed:20404107, PubMed:20798600, PubMed:22396657, PubMed:23620051, PubMed:23933751, PubMed:24898855, PubMed:32047033, PubMed:32484300). When cellular stress results in irreversible mitochondrial damage, PINK1 accumulates at the outer mitochondrial membrane (OMM) where it phosphorylates pre-existing polyubiquitin chains at 'Ser-65', recruits PRKN from the cytosol to the OMM and activates PRKN by phosphorylation at 'Ser-65'; activated PRKN then ubiquinates VDAC1 and other OMM proteins to initiate mitophagy (PubMed:14607334, PubMed:15087508, PubMed:19966284, PubMed:20404107, PubMed:20798600, PubMed:23754282, PubMed:23933751, PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25474007, PubMed:25527291, PubMed:32047033). The PINK1-PRKN pathway also promotes fission of damaged mitochondria through phosphorylation and PRKN-dependent degradation of mitochondrial proteins involved in fission such as MFN2 (PubMed:18443288, PubMed:23620051, PubMed:24898855). This prevents the refusion of unhealthy mitochondria with the mitochondrial network or initiates mitochondrial fragmentation facilitating their later engulfment by autophagosomes (PubMed:18443288, PubMed:23620051). Also promotes mitochondrial fission independently of PRKN and ATG7-mediated mitophagy, via the phosphorylation and activation of DNM1L (PubMed:18443288, PubMed:32484300). Regulates motility of damaged mitochondria by promoting the ubiquitination and subsequent degradation of MIRO1 and MIRO2; in motor neurons, this likely inhibits mitochondrial intracellular anterograde transport along the axons which probably increases the chance of the mitochondria undergoing mitophagy in the soma (PubMed:22396657). Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity). Phosphorylates LETM1, positively regulating its mitochondrial calcium transport activity (PubMed:29123128). {ECO:0000250|UniProtKB:Q99MQ3, ECO:0000269|PubMed:14607334, ECO:0000269|PubMed:15087508, ECO:0000269|PubMed:18443288, ECO:0000269|PubMed:18957282, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:19966284, ECO:0000269|PubMed:20404107, ECO:0000269|PubMed:20547144, ECO:0000269|PubMed:20798600, ECO:0000269|PubMed:22396657, ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:23754282, ECO:0000269|PubMed:23933751, ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:24896179, ECO:0000269|PubMed:24898855, ECO:0000269|PubMed:25474007, ECO:0000269|PubMed:25527291, ECO:0000269|PubMed:29123128, ECO:0000269|PubMed:32047033, ECO:0000269|PubMed:32484300}. |
Q9BXW9 | FANCD2 | S717 | ochoa|psp | Fanconi anemia group D2 protein (Protein FACD2) | Required for maintenance of chromosomal stability (PubMed:11239453, PubMed:14517836). Promotes accurate and efficient pairing of homologs during meiosis (PubMed:14517836). Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing (PubMed:15671039, PubMed:15650050, PubMed:30335751, PubMed:36385258). The FANCI-FANCD2 complex binds and scans double-stranded DNA (dsDNA) for DNA damage; this complex stalls at DNA junctions between double-stranded DNA and single-stranded DNA (By similarity). May participate in S phase and G2 phase checkpoint activation upon DNA damage (PubMed:15377654). Plays a role in preventing breakage and loss of missegregating chromatin at the end of cell division, particularly after replication stress (PubMed:15454491, PubMed:15661754). Required for the targeting, or stabilization, of BLM to non-centromeric abnormal structures induced by replicative stress (PubMed:15661754, PubMed:19465921). Promotes BRCA2/FANCD1 loading onto damaged chromatin (PubMed:11239454, PubMed:12239151, PubMed:12086603, PubMed:15115758, PubMed:15199141, PubMed:15671039, PubMed:18212739). May also be involved in B-cell immunoglobulin isotype switching. {ECO:0000250|UniProtKB:Q68Y81, ECO:0000269|PubMed:11239453, ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:12086603, ECO:0000269|PubMed:12239151, ECO:0000269|PubMed:14517836, ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15314022, ECO:0000269|PubMed:15377654, ECO:0000269|PubMed:15454491, ECO:0000269|PubMed:15650050, ECO:0000269|PubMed:15661754, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:19465921, ECO:0000269|PubMed:30335751, ECO:0000269|PubMed:36385258}. |
Q9BZL6 | PRKD2 | S706 | ochoa|psp | Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) | Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress-induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion (PubMed:14743217, PubMed:15604256, PubMed:16928771, PubMed:17077180, PubMed:17951978, PubMed:17962809, PubMed:18262756, PubMed:19001381, PubMed:19192391, PubMed:23503467, PubMed:28428613). May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression (By similarity). In response to oxidative stress, is phosphorylated at Tyr-438 and Tyr-717 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B (PubMed:15604256, PubMed:28428613). In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77 (PubMed:17962809). Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation (PubMed:17077180). During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens (By similarity). In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF-kappa-B-dependent pathway (PubMed:16928771). During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors (PubMed:19192391). In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane (PubMed:14743217). Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis (PubMed:19001381). In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN (PubMed:18262756). Downstream of PRKCA, plays important roles in angiotensin-2-induced monocyte adhesion to endothelial cells (PubMed:17951978). Plays a regulatory role in angiogenesis and tumor growth by phosphorylating a downstream mediator CIB1 isoform 2, resulting in vascular endothelial growth factor A (VEGFA) secretion (PubMed:23503467). {ECO:0000250|UniProtKB:Q8BZ03, ECO:0000269|PubMed:14743217, ECO:0000269|PubMed:15604256, ECO:0000269|PubMed:16928771, ECO:0000269|PubMed:17077180, ECO:0000269|PubMed:17951978, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:18262756, ECO:0000269|PubMed:19001381, ECO:0000269|PubMed:19192391, ECO:0000269|PubMed:23503467, ECO:0000269|PubMed:28428613}. |
Q9H0K1 | SIK2 | S379 | ochoa | Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2) | Serine/threonine-protein kinase that plays a role in many biological processes such as fatty acid oxidation, autophagy, immune response or glucose metabolism (PubMed:23322770, PubMed:26983400). Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators (PubMed:15454081). Phosphorylates EP300 and thus inhibits its histone acetyltransferase activity (PubMed:21084751, PubMed:26983400). In turn, regulates the DNA-binding ability of several transcription factors such as PPARA or MLXIPL (PubMed:21084751, PubMed:26983400). Also plays a role in thymic T-cell development (By similarity). {ECO:0000250|UniProtKB:Q8CFH6, ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:21084751, ECO:0000269|PubMed:23322770, ECO:0000269|PubMed:26983400}. |
Q9H1A4 | ANAPC1 | S547 | ochoa | Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein) | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle (PubMed:18485873). The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (PubMed:18485873). The APC/C complex catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (PubMed:29033132). {ECO:0000269|PubMed:18485873, ECO:0000269|PubMed:29033132}. |
Q9H4A5 | GOLPH3L | S112 | ochoa | Golgi phosphoprotein 3-like (GPP34-related protein) | Phosphatidylinositol-4-phosphate-binding protein that may antagonize the action of GOLPH3 which is required for the process of vesicle budding at the Golgi and anterograde transport to the plasma membrane. {ECO:0000269|PubMed:23345592}. |
Q9H7P9 | PLEKHG2 | S911 | ochoa | Pleckstrin homology domain-containing family G member 2 (PH domain-containing family G member 2) | May be a transforming oncogene with exchange activity for CDC42 (By similarity). May be a guanine-nucleotide exchange factor (GEF) for RAC1 and CDC42. Activated by the binding to subunits beta and gamma of the heterotrimeric guanine nucleotide-binding protein (G protein) (PubMed:18045877). Involved in the regulation of actin polymerization (PubMed:26573021). {ECO:0000250|UniProtKB:Q6KAU7, ECO:0000269|PubMed:18045877, ECO:0000269|PubMed:26573021}. |
Q9NPG3 | UBN1 | S142 | ochoa | Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein) | Acts as a novel regulator of senescence. Involved in the formation of senescence-associated heterochromatin foci (SAHF), which represses expression of proliferation-promoting genes. Binds to proliferation-promoting genes. May be required for replication-independent chromatin assembly. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:19029251}. |
Q9NRS6 | SNX15 | S201 | ochoa | Sorting nexin-15 | May be involved in several stages of intracellular trafficking. Overexpression of SNX15 disrupts the normal trafficking of proteins from the plasma membrane to recycling endosomes or the TGN. {ECO:0000269|PubMed:11085978}. |
Q9NUU7 | DDX19A | S92 | ochoa | ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) | ATP-dependent RNA helicase involved in mRNA export from the nucleus. Rather than unwinding RNA duplexes, DDX19 functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins. {ECO:0000250|UniProtKB:Q9UMR2}. |
Q9NWS6 | FAM118A | S311 | ochoa | Protein FAM118A | None |
Q9NYF8 | BCLAF1 | S564 | ochoa | Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1) | Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. {ECO:0000269|PubMed:18794151}. |
Q9NZ09 | UBAP1 | S217 | ochoa | Ubiquitin-associated protein 1 (UBAP-1) (Nasopharyngeal carcinoma-associated gene 20 protein) | Component of the ESCRT-I complex, a regulator of vesicular trafficking process (PubMed:21757351, PubMed:22405001, PubMed:31203368). Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs) (PubMed:21757351, PubMed:22405001). Plays a role in the proteasomal degradation of ubiquitinated cell-surface proteins, such as EGFR and BST2 (PubMed:22405001, PubMed:24284069, PubMed:31203368). {ECO:0000269|PubMed:21757351, ECO:0000269|PubMed:22405001, ECO:0000269|PubMed:24284069, ECO:0000269|PubMed:31203368}. |
Q9NZN5 | ARHGEF12 | S1176 | ochoa | Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) | May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13. {ECO:0000269|PubMed:11094164}. |
Q9UHB9 | SRP68 | S267 | ochoa | Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein) | Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) (PubMed:34020957). The SRP complex interacts with the signal sequence in nascent secretory and membrane proteins and directs them to the membrane of the ER (PubMed:34020957). The SRP complex targets the ribosome-nascent chain complex to the SRP receptor (SR), which is anchored in the ER, where SR compaction and GTPase rearrangement drive cotranslational protein translocation into the ER (PubMed:34020957). Binds the signal recognition particle RNA (7SL RNA), SRP72 binds to this complex subsequently (PubMed:16672232, PubMed:27899666). The SRP complex possibly participates in the elongation arrest function (By similarity). {ECO:0000250|UniProtKB:P38687, ECO:0000269|PubMed:16672232, ECO:0000269|PubMed:27899666, ECO:0000269|PubMed:34020957}. |
Q9UIG0 | BAZ1B | S508 | ochoa | Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2) | Atypical tyrosine-protein kinase that plays a central role in chromatin remodeling and acts as a transcription regulator (PubMed:19092802). Involved in DNA damage response by phosphorylating 'Tyr-142' of histone H2AX (H2AXY142ph) (PubMed:19092802, PubMed:19234442). H2AXY142ph plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress (PubMed:19092802, PubMed:19234442). Regulatory subunit of the ATP-dependent WICH-1 and WICH-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:11980720, PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). The WICH-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the WICH-5 ISWI chromatin remodeling complex (PubMed:28801535). The WICH-5 ISWI chromatin-remodeling complex regulates the transcription of various genes, has a role in RNA polymerase I transcription (By similarity). Within the B-WICH complex has a role in RNA polymerase III transcription (PubMed:16603771). Mediates the recruitment of the WICH-5 ISWI chromatin remodeling complex to replication foci during DNA replication (PubMed:15543136). {ECO:0000250|UniProtKB:Q9Z277, ECO:0000269|PubMed:11980720, ECO:0000269|PubMed:15543136, ECO:0000269|PubMed:16603771, ECO:0000269|PubMed:19092802, ECO:0000269|PubMed:19234442, ECO:0000269|PubMed:28801535}. |
Q9UL54 | TAOK2 | S656 | ochoa | Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2) | Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation. {ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:11279118, ECO:0000269|PubMed:12639963, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17158878, ECO:0000269|PubMed:17396146}. |
Q9UMR2 | DDX19B | S93 | ochoa|psp | ATP-dependent RNA helicase DDX19B (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B) | ATP-dependent RNA helicase involved in mRNA export from the nucleus (PubMed:10428971). Rather than unwinding RNA duplexes, DDX19B functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins (PubMed:10428971). {ECO:0000269|PubMed:10428971}. |
Q9UQ35 | SRRM2 | S1349 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQB8 | BAIAP2 | S453 | ochoa|psp | BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) | Adapter protein that links membrane-bound small G-proteins to cytoplasmic effector proteins. Necessary for CDC42-mediated reorganization of the actin cytoskeleton and for RAC1-mediated membrane ruffling. Involved in the regulation of the actin cytoskeleton by WASF family members and the Arp2/3 complex. Plays a role in neurite growth. Acts syngeristically with ENAH to promote filipodia formation. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. Participates in actin bundling when associated with EPS8, promoting filopodial protrusions. {ECO:0000269|PubMed:11130076, ECO:0000269|PubMed:11696321, ECO:0000269|PubMed:14752106, ECO:0000269|PubMed:17115031, ECO:0000269|PubMed:19366662}. |
Q9Y4W6 | AFG3L2 | S765 | ochoa | Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein) | Catalytic component of the m-AAA protease, a protease that plays a key role in proteostasis of inner mitochondrial membrane proteins, and which is essential for axonal and neuron development (PubMed:19748354, PubMed:28396416, PubMed:29932645, PubMed:30683687, PubMed:31327635, PubMed:37917749, PubMed:38157846). AFG3L2 possesses both ATPase and protease activities: the ATPase activity is required to unfold substrates, threading them into the internal proteolytic cavity for hydrolysis into small peptide fragments (PubMed:19748354, PubMed:31327635). The m-AAA protease carries out quality control in the inner membrane of the mitochondria by mediating degradation of mistranslated or misfolded polypeptides (PubMed:26504172, PubMed:30683687, PubMed:34718584). The m-AAA protease complex also promotes the processing and maturation of mitochondrial proteins, such as MRPL32/bL32m, PINK1 and SP7 (PubMed:22354088, PubMed:29932645, PubMed:30252181). Mediates protein maturation of the mitochondrial ribosomal subunit MRPL32/bL32m by catalyzing the cleavage of the presequence of MRPL32/bL32m prior to assembly into the mitochondrial ribosome (PubMed:29932645). Required for SPG7 maturation into its active mature form after SPG7 cleavage by mitochondrial-processing peptidase (MPP) (PubMed:30252181). Required for the maturation of PINK1 into its 52kDa mature form after its cleavage by mitochondrial-processing peptidase (MPP) (PubMed:22354088). Acts as a regulator of calcium in neurons by mediating degradation of SMDT1/EMRE before its assembly with the uniporter complex, limiting the availability of SMDT1/EMRE for MCU assembly and promoting efficient assembly of gatekeeper subunits with MCU (PubMed:27642048, PubMed:28396416). Promotes the proteolytic degradation of GHITM upon hyperpolarization of mitochondria: progressive GHITM degradation leads to respiratory complex I degradation and broad reshaping of the mitochondrial proteome by AFG3L2 (PubMed:35912435). Also acts as a regulator of mitochondrial glutathione homeostasis by mediating cleavage and degradation of SLC25A39 (PubMed:37917749, PubMed:38157846). SLC25A39 cleavage is prevented when SLC25A39 binds iron-sulfur (PubMed:37917749, PubMed:38157846). Involved in the regulation of OMA1-dependent processing of OPA1 (PubMed:17615298, PubMed:29545505, PubMed:30252181, PubMed:30683687, PubMed:32600459). May act by mediating processing of OMA1 precursor, participating in OMA1 maturation (PubMed:29545505). {ECO:0000269|PubMed:17615298, ECO:0000269|PubMed:19748354, ECO:0000269|PubMed:22354088, ECO:0000269|PubMed:26504172, ECO:0000269|PubMed:27642048, ECO:0000269|PubMed:28396416, ECO:0000269|PubMed:29545505, ECO:0000269|PubMed:29932645, ECO:0000269|PubMed:30252181, ECO:0000269|PubMed:30683687, ECO:0000269|PubMed:31327635, ECO:0000269|PubMed:32600459, ECO:0000269|PubMed:34718584, ECO:0000269|PubMed:35912435, ECO:0000269|PubMed:37917749, ECO:0000269|PubMed:38157846}. |
Q9Y5K6 | CD2AP | S458 | ochoa | CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains) | Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton (PubMed:10339567). In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis (PubMed:15800069). Plays a role in epithelial cell junctions formation (PubMed:22891260). {ECO:0000250|UniProtKB:F1LRS8, ECO:0000250|UniProtKB:Q9JLQ0, ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:22891260}. |
Q9Y6B6 | SAR1B | S162 | ochoa | Small COPII coat GTPase SAR1B (EC 3.6.5.2) (GTP-binding protein B) (GTBPB) (Secretion-associated Ras-related GTPase 1B) | Small GTPase that cycles between an active GTP-bound and an inactive GDP-bound state and mainly functions in vesicle-mediated endoplasmic reticulum (ER) to Golgi transport. The active GTP-bound form inserts into the endoplasmic reticulum membrane where it recruits the remainder of the coat protein complex II/COPII (PubMed:23433038, PubMed:32358066, PubMed:33186557, PubMed:36369712). The coat protein complex II assembling and polymerizing on endoplasmic reticulum membrane is responsible for both the sorting of cargos and the deformation and budding of membranes into vesicles destined to the Golgi (PubMed:23433038, PubMed:32358066, PubMed:33186557). In contrast to SAR1A, SAR1B specifically interacts with the cargo receptor SURF4 to mediate the transport of lipid-carrying lipoproteins including APOB and APOA1 from the endoplasmic reticulum to the Golgi and thereby, indirectly regulates lipid homeostasis (PubMed:32358066, PubMed:33186557). In addition to its role in vesicle trafficking, can also function as a leucine sensor regulating TORC1 signaling and more indirectly cellular metabolism, growth and survival. In absence of leucine, interacts with the GATOR2 complex via MIOS and inhibits TORC1 signaling. The binding of leucine abrogates the interaction with GATOR2 and the inhibition of the TORC1 signaling. This function is completely independent of the GTPase activity of SAR1B (PubMed:34290409). {ECO:0000269|PubMed:23433038, ECO:0000269|PubMed:32358066, ECO:0000269|PubMed:33186557, ECO:0000269|PubMed:34290409, ECO:0000269|PubMed:36369712}. |
Q9Y6E2 | BZW2 | S205 | ochoa | eIF5-mimic protein 1 (Basic leucine zipper and W2 domain-containing protein 2) | Translation initiation regulator which represses non-AUG initiated translation and repeat-associated non-AUG (RAN) initiated translation by acting as a competitive inhibitor of eukaryotic translation initiation factor 5 (EIF5) function (PubMed:21745818, PubMed:28981728, PubMed:29470543, PubMed:34260931). Increases the accuracy of translation initiation by impeding EIF5-dependent translation from non-AUG codons by competing with it for interaction with EIF2S2 within the 43S pre-initiation complex (PIC) in an EIF3C-binding dependent manner (PubMed:21745818, PubMed:28981728, PubMed:34260931). {ECO:0000269|PubMed:21745818, ECO:0000269|PubMed:28981728, ECO:0000269|PubMed:29470543, ECO:0000269|PubMed:34260931}. |
P11586 | MTHFD1 | S129 | Sugiyama | C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] | Trifunctional enzyme that catalyzes the interconversion of three forms of one-carbon-substituted tetrahydrofolate: (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, 5,10-methenyltetrahydrofolate and (6S)-10-formyltetrahydrofolate (PubMed:10828945, PubMed:18767138, PubMed:1881876). These derivatives of tetrahydrofolate are differentially required in nucleotide and amino acid biosynthesis, (6S)-10-formyltetrahydrofolate being required for purine biosynthesis while (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate is used for serine and methionine biosynthesis for instance (PubMed:18767138, PubMed:25633902). {ECO:0000269|PubMed:10828945, ECO:0000269|PubMed:18767138, ECO:0000269|PubMed:1881876, ECO:0000269|PubMed:25633902}. |
P39687 | ANP32A | S117 | Sugiyama | Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32) (pp32) (Leucine-rich acidic nuclear protein) (LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I) (PHAPI) | Multifunctional protein that is involved in the regulation of many processes including tumor suppression, apoptosis, cell cycle progression or transcription (PubMed:10400610, PubMed:11360199, PubMed:16341127, PubMed:18439902). Promotes apoptosis by favouring the activation of caspase-9/CASP9 and allowing apoptosome formation (PubMed:18439902). In addition, plays a role in the modulation of histone acetylation and transcription as part of the INHAT (inhibitor of histone acetyltransferases) complex. Inhibits the histone-acetyltranferase activity of EP300/CREBBP (CREB-binding protein) and EP300/CREBBP-associated factor by histone masking (PubMed:11830591). Preferentially binds to unmodified histone H3 and sterically inhibiting its acetylation and phosphorylation leading to cell growth inhibition (PubMed:16341127). Participates in other biochemical processes such as regulation of mRNA nuclear-to-cytoplasmic translocation and stability by its association with ELAVL1 (Hu-antigen R) (PubMed:18180367). Plays a role in E4F1-mediated transcriptional repression as well as inhibition of protein phosphatase 2A (PubMed:15642345, PubMed:17557114). {ECO:0000269|PubMed:10400610, ECO:0000269|PubMed:11360199, ECO:0000269|PubMed:11830591, ECO:0000269|PubMed:15642345, ECO:0000269|PubMed:16341127, ECO:0000269|PubMed:17557114, ECO:0000269|PubMed:18180367, ECO:0000269|PubMed:18439902}.; FUNCTION: (Microbial infection) Plays an essential role in influenza A, B and C viral genome replication (PubMed:30666459, PubMed:32694517, PubMed:33045004, PubMed:33208942). Mechanistically, mediates the assembly of the viral replicase asymmetric dimers composed of PB1, PB2 and PA via its N-terminal region (PubMed:33208942). Also plays an essential role in foamy virus mRNA export from the nucleus (PubMed:21159877). {ECO:0000269|PubMed:21159877, ECO:0000269|PubMed:30666459, ECO:0000269|PubMed:32694517, ECO:0000269|PubMed:33045004, ECO:0000269|PubMed:33208942}. |
Q92688 | ANP32B | S117 | Sugiyama | Acidic leucine-rich nuclear phosphoprotein 32 family member B (Acidic protein rich in leucines) (Putative HLA-DR-associated protein I-2) (PHAPI2) (Silver-stainable protein SSP29) | Multifunctional protein that is involved in the regulation of many processes including cell proliferation, apoptosis, cell cycle progression or transcription (PubMed:18039846, PubMed:20015864). Regulates the proliferation of neuronal stem cells, differentiation of leukemic cells and progression from G1 to S phase of the cell cycle. As negative regulator of caspase-3-dependent apoptosis, may act as an antagonist of ANP32A in regulating tissue homeostasis (PubMed:20015864). Exhibits histone chaperone properties, able to recruit histones to certain promoters, thus regulating the transcription of specific genes (PubMed:18039846, PubMed:20538007). Also plays an essential role in the nucleocytoplasmic transport of specific mRNAs via the uncommon nuclear mRNA export receptor XPO1/CRM1 (PubMed:17178712). Participates in the regulation of adequate adaptive immune responses by acting on mRNA expression and cell proliferation (By similarity). {ECO:0000250|UniProtKB:Q9EST5, ECO:0000269|PubMed:17178712, ECO:0000269|PubMed:18039846, ECO:0000269|PubMed:20015864, ECO:0000269|PubMed:20538007}.; FUNCTION: (Microbial infection) Plays an essential role in influenza A and B viral genome replication (PubMed:31217244, PubMed:33045004). Also plays a role in foamy virus mRNA export from the nucleus to the cytoplasm (PubMed:21159877). {ECO:0000269|PubMed:21159877, ECO:0000269|PubMed:31217244, ECO:0000269|PubMed:33045004}. |
P51811 | XK | S63 | ELM | Endoplasmic reticulum membrane adapter protein XK (Kell complex 37 kDa component) (Kx antigen) (Membrane transport protein XK) (XK-related protein 1) | Recruits the lipid transfer protein VPS13A from lipid droplets to the endoplasmic reticulum (ER) membrane. {ECO:0000269|PubMed:32845802}. |
Q99613 | EIF3C | S639 | Sugiyama | Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110) | Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03002, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}. |
P32119 | PRDX2 | S151 | Sugiyama | Peroxiredoxin-2 (EC 1.11.1.24) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2) | Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2). {ECO:0000269|PubMed:9497357}. |
Q16222 | UAP1 | S496 | Sugiyama | UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Protein-pyrophosphorylation enzyme) (EC 2.7.4.-) (Sperm-associated antigen 2) (UDP-N-acetylgalactosamine pyrophosphorylase) (EC 2.7.7.83) (UDP-N-acetylglucosamine pyrophosphorylase) (EC 2.7.7.23) | Catalyzes the last step in biosynthesis of uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) by converting UTP and glucosamine 1-phosphate (GlcNAc-1-P) to the sugar nucleotide (PubMed:9603950, PubMed:9765219). Also converts UTP and galactosamine 1-phosphate (GalNAc-1-P) into uridine diphosphate-N-acetylgalactosamine (UDP-GalNAc) (PubMed:9765219). In addition to its role in metabolism, acts as a regulator of innate immunity in response to virus infection by mediating pyrophosphorylation of IRF3: catalyzes pyrophosphorylation of IRF3 phosphorylated at 'Ser-386' by TBK1, promoting IRF3 dimerization and activation, leading to type I interferon responses (PubMed:36603579). {ECO:0000269|PubMed:36603579, ECO:0000269|PubMed:9603950, ECO:0000269|PubMed:9765219}.; FUNCTION: [Isoform AGX1]: Isoform AGX1 has 2 to 3 times higher activity towards galactosamine 1-phosphate (GalNAc-1-P). {ECO:0000269|PubMed:9765219}.; FUNCTION: [Isoform AGX1]: Isoform AGX2 has 8 times more activity towards glucosamine 1-phosphate (GlcNAc-1-P). {ECO:0000269|PubMed:9765219}. |
Q9Y5J9 | TIMM8B | S50 | Sugiyama | Mitochondrial import inner membrane translocase subunit Tim8 B (DDP-like protein) (Deafness dystonia protein 2) | Probable mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. Also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space (By similarity). {ECO:0000250}. |
Q16288 | NTRK3 | S706 | Sugiyama | NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase) | Receptor tyrosine kinase involved in nervous system and probably heart development. Upon binding of its ligand NTF3/neurotrophin-3, NTRK3 autophosphorylates and activates different signaling pathways, including the phosphatidylinositol 3-kinase/AKT and the MAPK pathways, that control cell survival and differentiation. {ECO:0000269|PubMed:25196463}. |
P27824 | CANX | S74 | Sugiyama | Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90) | Calcium-binding protein that interacts with newly synthesized monoglucosylated glycoproteins in the endoplasmic reticulum. It may act in assisting protein assembly and/or in the retention within the ER of unassembled protein subunits. It seems to play a major role in the quality control apparatus of the ER by the retention of incorrectly folded proteins. Associated with partial T-cell antigen receptor complexes that escape the ER of immature thymocytes, it may function as a signaling complex regulating thymocyte maturation. Additionally it may play a role in receptor-mediated endocytosis at the synapse. |
P62714 | PPP2CB | S75 | Sugiyama | Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (EC 3.1.3.16) | Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (Probable). PP2A can modulate the activity of phosphorylase B kinase, casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:18782753). {ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:2555176, ECO:0000305}. |
P67775 | PPP2CA | S75 | Sugiyama | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C) | Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:22613722, PubMed:33243860, PubMed:34004147, PubMed:9920888). PP2A is the major phosphatase for microtubule-associated proteins (MAPs) (PubMed:22613722). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase (PubMed:22613722). Cooperates with SGO2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I (By similarity). Can dephosphorylate various proteins, such as SV40 large T antigen, AXIN1, p53/TP53, PIM3, WEE1 (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:9920888). Activates RAF1 by dephosphorylating it at 'Ser-259' (PubMed:10801873). Mediates dephosphorylation of WEE1, preventing its ubiquitin-mediated proteolysis, increasing WEE1 protein levels, and promoting the G2/M checkpoint (PubMed:33108758). Mediates dephosphorylation of MYC; promoting its ubiquitin-mediated proteolysis: interaction with AMBRA1 enhances interaction between PPP2CA and MYC (PubMed:25438055). Mediates dephosphorylation of FOXO3; promoting its stabilization: interaction with AMBRA1 enhances interaction between PPP2CA and FOXO3 (PubMed:30513302). Catalyzes dephosphorylation of the pyrin domain of NLRP3, promoting assembly of the NLRP3 inflammasome (By similarity). Together with RACK1 adapter, mediates dephosphorylation of AKT1 at 'Ser-473', preventing AKT1 activation and AKT-mTOR signaling pathway (By similarity). Dephosphorylation of AKT1 is essential for regulatory T-cells (Treg) homeostasis and stability (By similarity). Catalyzes dephosphorylation of PIM3, promotinh PIM3 ubiquitination and proteasomal degradation (PubMed:12473674). Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes (PubMed:33633399). STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling (PubMed:33633399). Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:33633399). Key mediator of a quality checkpoint during transcription elongation as part of the Integrator-PP2A (INTAC) complex (PubMed:33243860, PubMed:34004147, PubMed:37080207). The INTAC complex drives premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: within the INTAC complex, PPP2CA catalyzes dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A/RPB1 and SUPT5H/SPT5, thereby preventing transcriptional elongation (PubMed:33243860, PubMed:34004147, PubMed:37080207). {ECO:0000250|UniProtKB:P63330, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:12473674, ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:22613722, ECO:0000269|PubMed:25438055, ECO:0000269|PubMed:30513302, ECO:0000269|PubMed:33108758, ECO:0000269|PubMed:33243860, ECO:0000269|PubMed:33633399, ECO:0000269|PubMed:34004147, ECO:0000269|PubMed:37080207, ECO:0000269|PubMed:9920888}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 0.000059 | 4.230 |
R-HSA-447115 | Interleukin-12 family signaling | 0.000030 | 4.521 |
R-HSA-419812 | Calcitonin-like ligand receptors | 0.000148 | 3.831 |
R-HSA-9020591 | Interleukin-12 signaling | 0.000126 | 3.899 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.000800 | 3.097 |
R-HSA-9705677 | SARS-CoV-2 targets PDZ proteins in cell-cell junction | 0.001399 | 2.854 |
R-HSA-5654738 | Signaling by FGFR2 | 0.001289 | 2.890 |
R-HSA-4411364 | Binding of TCF/LEF:CTNNB1 to target gene promoters | 0.003795 | 2.421 |
R-HSA-163767 | PP2A-mediated dephosphorylation of key metabolic factors | 0.003795 | 2.421 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 0.007266 | 2.139 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 0.007266 | 2.139 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 0.007266 | 2.139 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 0.008293 | 2.081 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 0.009380 | 2.028 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 0.009380 | 2.028 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 0.009380 | 2.028 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 0.009380 | 2.028 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 0.009380 | 2.028 |
R-HSA-6803529 | FGFR2 alternative splicing | 0.002176 | 2.662 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.002993 | 2.524 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 0.005662 | 2.247 |
R-HSA-4641265 | Repression of WNT target genes | 0.009380 | 2.028 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.003495 | 2.457 |
R-HSA-8951430 | RUNX3 regulates WNT signaling | 0.003795 | 2.421 |
R-HSA-4839744 | Signaling by APC mutants | 0.007266 | 2.139 |
R-HSA-202670 | ERKs are inactivated | 0.008293 | 2.081 |
R-HSA-4839748 | Signaling by AMER1 mutants | 0.008293 | 2.081 |
R-HSA-4839735 | Signaling by AXIN mutants | 0.008293 | 2.081 |
R-HSA-9612973 | Autophagy | 0.005173 | 2.286 |
R-HSA-8935964 | RUNX1 regulates expression of components of tight junctions | 0.002458 | 2.609 |
R-HSA-113501 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 0.008293 | 2.081 |
R-HSA-450520 | HuR (ELAVL1) binds and stabilizes mRNA | 0.005402 | 2.267 |
R-HSA-199991 | Membrane Trafficking | 0.007706 | 2.113 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.004095 | 2.388 |
R-HSA-2465910 | MASTL Facilitates Mitotic Progression | 0.005402 | 2.267 |
R-HSA-190236 | Signaling by FGFR | 0.003237 | 2.490 |
R-HSA-449147 | Signaling by Interleukins | 0.005826 | 2.235 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.010703 | 1.970 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.010703 | 1.970 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 0.012998 | 1.886 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.013136 | 1.882 |
R-HSA-1295596 | Spry regulation of FGF signaling | 0.012998 | 1.886 |
R-HSA-2032785 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | 0.011734 | 1.931 |
R-HSA-9663891 | Selective autophagy | 0.011890 | 1.925 |
R-HSA-9634600 | Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 0.014318 | 1.844 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.012964 | 1.887 |
R-HSA-75153 | Apoptotic execution phase | 0.013182 | 1.880 |
R-HSA-1632852 | Macroautophagy | 0.014649 | 1.834 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.014863 | 1.828 |
R-HSA-1280218 | Adaptive Immune System | 0.015963 | 1.797 |
R-HSA-72172 | mRNA Splicing | 0.016419 | 1.785 |
R-HSA-5602566 | TICAM1 deficiency - HSE | 0.017849 | 1.748 |
R-HSA-2028269 | Signaling by Hippo | 0.017124 | 1.766 |
R-HSA-9614657 | FOXO-mediated transcription of cell death genes | 0.018607 | 1.730 |
R-HSA-432142 | Platelet sensitization by LDL | 0.018607 | 1.730 |
R-HSA-389513 | Co-inhibition by CTLA4 | 0.021730 | 1.663 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.025105 | 1.600 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 0.020143 | 1.696 |
R-HSA-373753 | Nephrin family interactions | 0.021730 | 1.663 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.024455 | 1.612 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 0.025053 | 1.601 |
R-HSA-198753 | ERK/MAPK targets | 0.023367 | 1.631 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.019418 | 1.712 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 0.024050 | 1.619 |
R-HSA-109581 | Apoptosis | 0.024090 | 1.618 |
R-HSA-9603505 | NTRK3 as a dependence receptor | 0.026654 | 1.574 |
R-HSA-5602571 | TRAF3 deficiency - HSE | 0.026654 | 1.574 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 0.028568 | 1.544 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.028888 | 1.539 |
R-HSA-9034013 | NTF3 activates NTRK3 signaling | 0.035382 | 1.451 |
R-HSA-9615710 | Late endosomal microautophagy | 0.040192 | 1.396 |
R-HSA-420029 | Tight junction interactions | 0.032268 | 1.491 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 0.038148 | 1.419 |
R-HSA-5654732 | Negative regulation of FGFR3 signaling | 0.038148 | 1.419 |
R-HSA-5654733 | Negative regulation of FGFR4 signaling | 0.040192 | 1.396 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.034473 | 1.463 |
R-HSA-2132295 | MHC class II antigen presentation | 0.036072 | 1.443 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 0.036146 | 1.442 |
R-HSA-5653656 | Vesicle-mediated transport | 0.037177 | 1.430 |
R-HSA-1660514 | Synthesis of PIPs at the Golgi membrane | 0.034185 | 1.466 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.037400 | 1.427 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.043357 | 1.363 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.029824 | 1.525 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 0.030396 | 1.517 |
R-HSA-8863678 | Neurodegenerative Diseases | 0.030396 | 1.517 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 0.036146 | 1.442 |
R-HSA-180024 | DARPP-32 events | 0.040192 | 1.396 |
R-HSA-168256 | Immune System | 0.037218 | 1.429 |
R-HSA-9008059 | Interleukin-37 signaling | 0.042277 | 1.374 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.034473 | 1.463 |
R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 0.040192 | 1.396 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.032491 | 1.488 |
R-HSA-212436 | Generic Transcription Pathway | 0.043860 | 1.358 |
R-HSA-9034793 | Activated NTRK3 signals through PLCG1 | 0.044031 | 1.356 |
R-HSA-111446 | Activation of BIM and translocation to mitochondria | 0.044031 | 1.356 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.045624 | 1.341 |
R-HSA-9833482 | PKR-mediated signaling | 0.045865 | 1.339 |
R-HSA-4791275 | Signaling by WNT in cancer | 0.046565 | 1.332 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.046565 | 1.332 |
R-HSA-162582 | Signal Transduction | 0.047506 | 1.323 |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | 0.048767 | 1.312 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.048767 | 1.312 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.048944 | 1.310 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.050390 | 1.298 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 0.051005 | 1.292 |
R-HSA-9013957 | TLR3-mediated TICAM1-dependent programmed cell death | 0.052603 | 1.279 |
R-HSA-191650 | Regulation of gap junction activity | 0.052603 | 1.279 |
R-HSA-983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 0.053280 | 1.273 |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | 0.053280 | 1.273 |
R-HSA-5205647 | Mitophagy | 0.053280 | 1.273 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.054394 | 1.264 |
R-HSA-195721 | Signaling by WNT | 0.068828 | 1.162 |
R-HSA-68882 | Mitotic Anaphase | 0.063236 | 1.199 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.060315 | 1.220 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.064143 | 1.193 |
R-HSA-5673000 | RAF activation | 0.053280 | 1.273 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.067402 | 1.171 |
R-HSA-373080 | Class B/2 (Secretin family receptors) | 0.060898 | 1.215 |
R-HSA-6804757 | Regulation of TP53 Degradation | 0.057936 | 1.237 |
R-HSA-168316 | Assembly of Viral Components at the Budding Site | 0.061099 | 1.214 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 0.065172 | 1.186 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.056721 | 1.246 |
R-HSA-5357801 | Programmed Cell Death | 0.053745 | 1.270 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.069255 | 1.160 |
R-HSA-8951671 | RUNX3 regulates YAP1-mediated transcription | 0.077865 | 1.109 |
R-HSA-9603381 | Activated NTRK3 signals through PI3K | 0.086136 | 1.065 |
R-HSA-2562578 | TRIF-mediated programmed cell death | 0.086136 | 1.065 |
R-HSA-9828211 | Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | 0.094333 | 1.025 |
R-HSA-9613354 | Lipophagy | 0.102457 | 0.989 |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | 0.110509 | 0.957 |
R-HSA-9034864 | Activated NTRK3 signals through RAS | 0.118489 | 0.926 |
R-HSA-5358493 | Synthesis of diphthamide-EEF2 | 0.126398 | 0.898 |
R-HSA-9824878 | Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | 0.126398 | 0.898 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.142006 | 0.848 |
R-HSA-2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 0.157336 | 0.803 |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | 0.157336 | 0.803 |
R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | 0.157336 | 0.803 |
R-HSA-176412 | Phosphorylation of the APC/C | 0.164899 | 0.783 |
R-HSA-9687136 | Aberrant regulation of mitotic exit in cancer due to RB1 defects | 0.164899 | 0.783 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 0.194482 | 0.711 |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | 0.194482 | 0.711 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 0.208881 | 0.680 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 0.105226 | 0.978 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.119753 | 0.922 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 0.140851 | 0.851 |
R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | 0.126398 | 0.898 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 0.172394 | 0.763 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.127156 | 0.896 |
R-HSA-176407 | Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 0.179823 | 0.745 |
R-HSA-8949664 | Processing of SMDT1 | 0.142006 | 0.848 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 0.083126 | 1.080 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.204546 | 0.689 |
R-HSA-209560 | NF-kB is activated and signals survival | 0.126398 | 0.898 |
R-HSA-174490 | Membrane binding and targetting of GAG proteins | 0.142006 | 0.848 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 0.172394 | 0.763 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 0.201714 | 0.695 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.143463 | 0.843 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 0.187185 | 0.728 |
R-HSA-193639 | p75NTR signals via NF-kB | 0.157336 | 0.803 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 0.073095 | 1.136 |
R-HSA-209543 | p75NTR recruits signalling complexes | 0.134237 | 0.872 |
R-HSA-204005 | COPII-mediated vesicle transport | 0.156371 | 0.806 |
R-HSA-392517 | Rap1 signalling | 0.194482 | 0.711 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 0.159513 | 0.797 |
R-HSA-1855191 | Synthesis of IPs in the nucleus | 0.149705 | 0.825 |
R-HSA-174495 | Synthesis And Processing Of GAG, GAGPOL Polyproteins | 0.149705 | 0.825 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 0.171320 | 0.766 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.098601 | 1.006 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.089737 | 1.047 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.098601 | 1.006 |
R-HSA-9706019 | RHOBTB3 ATPase cycle | 0.118489 | 0.926 |
R-HSA-399954 | Sema3A PAK dependent Axon repulsion | 0.157336 | 0.803 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 0.172394 | 0.763 |
R-HSA-9664407 | Parasite infection | 0.169123 | 0.772 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.169123 | 0.772 |
R-HSA-9664417 | Leishmania phagocytosis | 0.169123 | 0.772 |
R-HSA-68877 | Mitotic Prometaphase | 0.125585 | 0.901 |
R-HSA-9664873 | Pexophagy | 0.110509 | 0.957 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 0.149705 | 0.825 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 0.201714 | 0.695 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.158691 | 0.799 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.110549 | 0.956 |
R-HSA-428890 | Role of ABL in ROBO-SLIT signaling | 0.086136 | 1.065 |
R-HSA-425381 | Bicarbonate transporters | 0.118489 | 0.926 |
R-HSA-9796292 | Formation of axial mesoderm | 0.142006 | 0.848 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 0.157336 | 0.803 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 0.088505 | 1.053 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.189177 | 0.723 |
R-HSA-438064 | Post NMDA receptor activation events | 0.214384 | 0.669 |
R-HSA-164944 | Nef and signal transduction | 0.077865 | 1.109 |
R-HSA-5336415 | Uptake and function of diphtheria toxin | 0.086136 | 1.065 |
R-HSA-167590 | Nef Mediated CD4 Down-regulation | 0.086136 | 1.065 |
R-HSA-8963888 | Chylomicron assembly | 0.118489 | 0.926 |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 0.149705 | 0.825 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.181816 | 0.740 |
R-HSA-3928664 | Ephrin signaling | 0.187185 | 0.728 |
R-HSA-9754189 | Germ layer formation at gastrulation | 0.194482 | 0.711 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.150123 | 0.824 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.077930 | 1.108 |
R-HSA-5654743 | Signaling by FGFR4 | 0.077853 | 1.109 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.202871 | 0.693 |
R-HSA-5578768 | Physiological factors | 0.149705 | 0.825 |
R-HSA-388844 | Receptor-type tyrosine-protein phosphatases | 0.164899 | 0.783 |
R-HSA-9909505 | Modulation of host responses by IFN-stimulated genes | 0.179823 | 0.745 |
R-HSA-4086400 | PCP/CE pathway | 0.181816 | 0.740 |
R-HSA-5654741 | Signaling by FGFR3 | 0.083126 | 1.080 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.147758 | 0.830 |
R-HSA-9659379 | Sensory processing of sound | 0.185040 | 0.733 |
R-HSA-977225 | Amyloid fiber formation | 0.191513 | 0.718 |
R-HSA-9020956 | Interleukin-27 signaling | 0.110509 | 0.957 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 0.109683 | 0.960 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.157638 | 0.802 |
R-HSA-5654736 | Signaling by FGFR1 | 0.113883 | 0.944 |
R-HSA-210990 | PECAM1 interactions | 0.118489 | 0.926 |
R-HSA-9856872 | Malate-aspartate shuttle | 0.149705 | 0.825 |
R-HSA-1237112 | Methionine salvage pathway | 0.194482 | 0.711 |
R-HSA-193648 | NRAGE signals death through JNK | 0.113883 | 0.944 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.150123 | 0.824 |
R-HSA-9834899 | Specification of the neural plate border | 0.194482 | 0.711 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.074692 | 1.127 |
R-HSA-9683686 | Maturation of spike protein | 0.110509 | 0.957 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 0.134237 | 0.872 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.113883 | 0.944 |
R-HSA-166520 | Signaling by NTRKs | 0.189177 | 0.723 |
R-HSA-69236 | G1 Phase | 0.080476 | 1.094 |
R-HSA-69231 | Cyclin D associated events in G1 | 0.080476 | 1.094 |
R-HSA-5683057 | MAPK family signaling cascades | 0.115316 | 0.938 |
R-HSA-8876725 | Protein methylation | 0.157336 | 0.803 |
R-HSA-140534 | Caspase activation via Death Receptors in the presence of ligand | 0.164899 | 0.783 |
R-HSA-389356 | Co-stimulation by CD28 | 0.091233 | 1.040 |
R-HSA-9711123 | Cellular response to chemical stress | 0.119834 | 0.921 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 0.094333 | 1.025 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 0.102457 | 0.989 |
R-HSA-373755 | Semaphorin interactions | 0.134742 | 0.870 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 0.187185 | 0.728 |
R-HSA-180292 | GAB1 signalosome | 0.187185 | 0.728 |
R-HSA-9706369 | Negative regulation of FLT3 | 0.164899 | 0.783 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.107506 | 0.969 |
R-HSA-8984722 | Interleukin-35 Signalling | 0.134237 | 0.872 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 0.162668 | 0.789 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.211099 | 0.676 |
R-HSA-73887 | Death Receptor Signaling | 0.202871 | 0.693 |
R-HSA-4086398 | Ca2+ pathway | 0.165834 | 0.780 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.210072 | 0.678 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.095020 | 1.022 |
R-HSA-164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to cla... | 0.179823 | 0.745 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.111576 | 0.952 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.131710 | 0.880 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.204546 | 0.689 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 0.072692 | 1.139 |
R-HSA-194138 | Signaling by VEGF | 0.133190 | 0.876 |
R-HSA-1500931 | Cell-Cell communication | 0.084373 | 1.074 |
R-HSA-168268 | Virus Assembly and Release | 0.164899 | 0.783 |
R-HSA-74160 | Gene expression (Transcription) | 0.083376 | 1.079 |
R-HSA-1483255 | PI Metabolism | 0.082901 | 1.081 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.078125 | 1.107 |
R-HSA-177929 | Signaling by EGFR | 0.113883 | 0.944 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.095013 | 1.022 |
R-HSA-450294 | MAP kinase activation | 0.128696 | 0.890 |
R-HSA-3299685 | Detoxification of Reactive Oxygen Species | 0.113883 | 0.944 |
R-HSA-448424 | Interleukin-17 signaling | 0.156371 | 0.806 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.096800 | 1.014 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.104083 | 0.983 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.109683 | 0.960 |
R-HSA-446652 | Interleukin-1 family signaling | 0.198280 | 0.703 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 0.162668 | 0.789 |
R-HSA-9034015 | Signaling by NTRK3 (TRKC) | 0.215984 | 0.666 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 0.215984 | 0.666 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 0.215984 | 0.666 |
R-HSA-8949215 | Mitochondrial calcium ion transport | 0.215984 | 0.666 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.215984 | 0.666 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 0.215984 | 0.666 |
R-HSA-175474 | Assembly Of The HIV Virion | 0.215984 | 0.666 |
R-HSA-9645723 | Diseases of programmed cell death | 0.217674 | 0.662 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 0.223024 | 0.652 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.224266 | 0.649 |
R-HSA-421270 | Cell-cell junction organization | 0.228714 | 0.641 |
R-HSA-912526 | Interleukin receptor SHC signaling | 0.230002 | 0.638 |
R-HSA-446210 | Synthesis of UDP-N-acetyl-glucosamine | 0.230002 | 0.638 |
R-HSA-8963898 | Plasma lipoprotein assembly | 0.236917 | 0.625 |
R-HSA-9620244 | Long-term potentiation | 0.243770 | 0.613 |
R-HSA-9839394 | TGFBR3 expression | 0.243770 | 0.613 |
R-HSA-400685 | Sema4D in semaphorin signaling | 0.243770 | 0.613 |
R-HSA-418555 | G alpha (s) signalling events | 0.245188 | 0.611 |
R-HSA-525793 | Myogenesis | 0.250562 | 0.601 |
R-HSA-5357769 | Caspase activation via extrinsic apoptotic signalling pathway | 0.250562 | 0.601 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.252382 | 0.598 |
R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 0.257294 | 0.590 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 0.257294 | 0.590 |
R-HSA-202427 | Phosphorylation of CD3 and TCR zeta chains | 0.257294 | 0.590 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 0.257294 | 0.590 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.257409 | 0.589 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.257409 | 0.589 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.257409 | 0.589 |
R-HSA-9614085 | FOXO-mediated transcription | 0.260732 | 0.584 |
R-HSA-6798695 | Neutrophil degranulation | 0.262259 | 0.581 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 0.263965 | 0.578 |
R-HSA-171319 | Telomere Extension By Telomerase | 0.263965 | 0.578 |
R-HSA-70171 | Glycolysis | 0.264056 | 0.578 |
R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) | 0.270577 | 0.568 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 0.270577 | 0.568 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 0.270704 | 0.568 |
R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 0.277130 | 0.557 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 0.277130 | 0.557 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 0.277130 | 0.557 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 0.277130 | 0.557 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 0.277130 | 0.557 |
R-HSA-114452 | Activation of BH3-only proteins | 0.277130 | 0.557 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 0.277130 | 0.557 |
R-HSA-111885 | Opioid Signalling | 0.277351 | 0.557 |
R-HSA-69275 | G2/M Transition | 0.281437 | 0.551 |
R-HSA-446728 | Cell junction organization | 0.281580 | 0.550 |
R-HSA-162588 | Budding and maturation of HIV virion | 0.283625 | 0.547 |
R-HSA-8963693 | Aspartate and asparagine metabolism | 0.283625 | 0.547 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 0.283625 | 0.547 |
R-HSA-5694530 | Cargo concentration in the ER | 0.283625 | 0.547 |
R-HSA-182971 | EGFR downregulation | 0.283625 | 0.547 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.286313 | 0.543 |
R-HSA-418346 | Platelet homeostasis | 0.287315 | 0.542 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.289586 | 0.538 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 0.290061 | 0.538 |
R-HSA-5617833 | Cilium Assembly | 0.291196 | 0.536 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.293640 | 0.532 |
R-HSA-354192 | Integrin signaling | 0.296440 | 0.528 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 0.296440 | 0.528 |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | 0.296440 | 0.528 |
R-HSA-68886 | M Phase | 0.298163 | 0.526 |
R-HSA-202403 | TCR signaling | 0.300577 | 0.522 |
R-HSA-390522 | Striated Muscle Contraction | 0.302763 | 0.519 |
R-HSA-9768727 | Regulation of CDH1 posttranslational processing and trafficking to plasma membra... | 0.302763 | 0.519 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 0.302763 | 0.519 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.307194 | 0.513 |
R-HSA-901042 | Calnexin/calreticulin cycle | 0.309028 | 0.510 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 0.309028 | 0.510 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.315238 | 0.501 |
R-HSA-428157 | Sphingolipid metabolism | 0.318140 | 0.497 |
R-HSA-432720 | Lysosome Vesicle Biogenesis | 0.321393 | 0.493 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.321393 | 0.493 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.321393 | 0.493 |
R-HSA-9845576 | Glycosphingolipid transport | 0.321393 | 0.493 |
R-HSA-163560 | Triglyceride catabolism | 0.321393 | 0.493 |
R-HSA-8941326 | RUNX2 regulates bone development | 0.321393 | 0.493 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 0.327492 | 0.485 |
R-HSA-196757 | Metabolism of folate and pterines | 0.327492 | 0.485 |
R-HSA-70326 | Glucose metabolism | 0.330250 | 0.481 |
R-HSA-9958790 | SLC-mediated transport of inorganic anions | 0.333537 | 0.477 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.336801 | 0.473 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.336801 | 0.473 |
R-HSA-68875 | Mitotic Prophase | 0.340070 | 0.468 |
R-HSA-9646399 | Aggrephagy | 0.345466 | 0.462 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 0.345466 | 0.462 |
R-HSA-5260271 | Diseases of Immune System | 0.345466 | 0.462 |
R-HSA-451927 | Interleukin-2 family signaling | 0.345466 | 0.462 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.346593 | 0.460 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.346593 | 0.460 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 0.351351 | 0.454 |
R-HSA-73817 | Purine ribonucleoside monophosphate biosynthesis | 0.351351 | 0.454 |
R-HSA-9694548 | Maturation of spike protein | 0.351351 | 0.454 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 0.351351 | 0.454 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 0.351351 | 0.454 |
R-HSA-9607240 | FLT3 Signaling | 0.351351 | 0.454 |
R-HSA-162909 | Host Interactions of HIV factors | 0.353095 | 0.452 |
R-HSA-5674135 | MAP2K and MAPK activation | 0.357183 | 0.447 |
R-HSA-9656223 | Signaling by RAF1 mutants | 0.357183 | 0.447 |
R-HSA-6811438 | Intra-Golgi traffic | 0.357183 | 0.447 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 0.357183 | 0.447 |
R-HSA-9683701 | Translation of Structural Proteins | 0.357183 | 0.447 |
R-HSA-69206 | G1/S Transition | 0.359574 | 0.444 |
R-HSA-165159 | MTOR signalling | 0.362963 | 0.440 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.362963 | 0.440 |
R-HSA-8953854 | Metabolism of RNA | 0.365592 | 0.437 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 0.369249 | 0.433 |
R-HSA-9907900 | Proteasome assembly | 0.374368 | 0.427 |
R-HSA-6783310 | Fanconi Anemia Pathway | 0.379995 | 0.420 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 0.379995 | 0.420 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.381777 | 0.418 |
R-HSA-5576891 | Cardiac conduction | 0.382060 | 0.418 |
R-HSA-162906 | HIV Infection | 0.384207 | 0.415 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 0.385571 | 0.414 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 0.385571 | 0.414 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 0.385571 | 0.414 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 0.385571 | 0.414 |
R-HSA-6802949 | Signaling by RAS mutants | 0.385571 | 0.414 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 0.385571 | 0.414 |
R-HSA-9839373 | Signaling by TGFBR3 | 0.385571 | 0.414 |
R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade | 0.385571 | 0.414 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.386635 | 0.413 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 0.391097 | 0.408 |
R-HSA-5620924 | Intraflagellar transport | 0.396575 | 0.402 |
R-HSA-163685 | Integration of energy metabolism | 0.401068 | 0.397 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 0.402003 | 0.396 |
R-HSA-157858 | Gap junction trafficking and regulation | 0.402003 | 0.396 |
R-HSA-73893 | DNA Damage Bypass | 0.402003 | 0.396 |
R-HSA-9748787 | Azathioprine ADME | 0.407382 | 0.390 |
R-HSA-2514856 | The phototransduction cascade | 0.412714 | 0.384 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 0.417998 | 0.379 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 0.417998 | 0.379 |
R-HSA-6794361 | Neurexins and neuroligins | 0.417998 | 0.379 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 0.417998 | 0.379 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 0.423235 | 0.373 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 0.423235 | 0.373 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 0.423235 | 0.373 |
R-HSA-8956320 | Nucleotide biosynthesis | 0.423235 | 0.373 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.425485 | 0.371 |
R-HSA-72649 | Translation initiation complex formation | 0.428424 | 0.368 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 0.428424 | 0.368 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 0.433568 | 0.363 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.433568 | 0.363 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.435183 | 0.361 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 0.438666 | 0.358 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 0.438666 | 0.358 |
R-HSA-5578775 | Ion homeostasis | 0.438666 | 0.358 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 0.438666 | 0.358 |
R-HSA-168249 | Innate Immune System | 0.442610 | 0.354 |
R-HSA-9758941 | Gastrulation | 0.444309 | 0.352 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.447332 | 0.349 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 0.448724 | 0.348 |
R-HSA-180786 | Extension of Telomeres | 0.453687 | 0.343 |
R-HSA-8979227 | Triglyceride metabolism | 0.453687 | 0.343 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.453687 | 0.343 |
R-HSA-8873719 | RAB geranylgeranylation | 0.458604 | 0.339 |
R-HSA-1227986 | Signaling by ERBB2 | 0.458604 | 0.339 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 0.458604 | 0.339 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 0.468308 | 0.329 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 0.468308 | 0.329 |
R-HSA-1268020 | Mitochondrial protein import | 0.468308 | 0.329 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.468308 | 0.329 |
R-HSA-186797 | Signaling by PDGF | 0.468308 | 0.329 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.473095 | 0.325 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.473095 | 0.325 |
R-HSA-8848021 | Signaling by PTK6 | 0.473095 | 0.325 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.473095 | 0.325 |
R-HSA-9006936 | Signaling by TGFB family members | 0.477056 | 0.321 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.487201 | 0.312 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.491819 | 0.308 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 0.505427 | 0.296 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.505427 | 0.296 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 0.509882 | 0.293 |
R-HSA-453276 | Regulation of mitotic cell cycle | 0.509882 | 0.293 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.509882 | 0.293 |
R-HSA-9658195 | Leishmania infection | 0.510549 | 0.292 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.510549 | 0.292 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 0.514297 | 0.289 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.517008 | 0.287 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.517008 | 0.287 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.518673 | 0.285 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 0.518673 | 0.285 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.518673 | 0.285 |
R-HSA-380287 | Centrosome maturation | 0.527307 | 0.278 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.527307 | 0.278 |
R-HSA-8852135 | Protein ubiquitination | 0.527307 | 0.278 |
R-HSA-611105 | Respiratory electron transport | 0.530784 | 0.275 |
R-HSA-9694635 | Translation of Structural Proteins | 0.535787 | 0.271 |
R-HSA-2559583 | Cellular Senescence | 0.536220 | 0.271 |
R-HSA-372790 | Signaling by GPCR | 0.537436 | 0.270 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.539971 | 0.268 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.541134 | 0.267 |
R-HSA-1483257 | Phospholipid metabolism | 0.541134 | 0.267 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.544117 | 0.264 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.548225 | 0.261 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 0.556333 | 0.255 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.564296 | 0.248 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 0.564296 | 0.248 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.568224 | 0.245 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 0.572117 | 0.243 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.575975 | 0.240 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 0.575975 | 0.240 |
R-HSA-1614635 | Sulfur amino acid metabolism | 0.575975 | 0.240 |
R-HSA-388396 | GPCR downstream signalling | 0.577925 | 0.238 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.578144 | 0.238 |
R-HSA-72766 | Translation | 0.579508 | 0.237 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.583588 | 0.234 |
R-HSA-156902 | Peptide chain elongation | 0.583588 | 0.234 |
R-HSA-9824446 | Viral Infection Pathways | 0.589477 | 0.230 |
R-HSA-202424 | Downstream TCR signaling | 0.591066 | 0.228 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.592942 | 0.227 |
R-HSA-9679506 | SARS-CoV Infections | 0.595269 | 0.225 |
R-HSA-2262752 | Cellular responses to stress | 0.595931 | 0.225 |
R-HSA-156842 | Eukaryotic Translation Elongation | 0.602032 | 0.220 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.602032 | 0.220 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.602032 | 0.220 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 0.602032 | 0.220 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.605622 | 0.218 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.609180 | 0.215 |
R-HSA-9837999 | Mitochondrial protein degradation | 0.609180 | 0.215 |
R-HSA-8953897 | Cellular responses to stimuli | 0.609462 | 0.215 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.612064 | 0.213 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.612706 | 0.213 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 0.616201 | 0.210 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.619605 | 0.208 |
R-HSA-397014 | Muscle contraction | 0.619605 | 0.208 |
R-HSA-5389840 | Mitochondrial translation elongation | 0.619664 | 0.208 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.621945 | 0.206 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.623096 | 0.205 |
R-HSA-157579 | Telomere Maintenance | 0.623096 | 0.205 |
R-HSA-5368286 | Mitochondrial translation initiation | 0.626498 | 0.203 |
R-HSA-418990 | Adherens junctions interactions | 0.633477 | 0.198 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.635326 | 0.197 |
R-HSA-9675108 | Nervous system development | 0.635769 | 0.197 |
R-HSA-9020702 | Interleukin-1 signaling | 0.636520 | 0.196 |
R-HSA-9937383 | Mitochondrial ribosome-associated quality control | 0.643053 | 0.192 |
R-HSA-112316 | Neuronal System | 0.644884 | 0.191 |
R-HSA-1640170 | Cell Cycle | 0.645440 | 0.190 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.646275 | 0.190 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.646275 | 0.190 |
R-HSA-9833110 | RSV-host interactions | 0.649469 | 0.187 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.658879 | 0.181 |
R-HSA-69239 | Synthesis of DNA | 0.658879 | 0.181 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.658879 | 0.181 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.658879 | 0.181 |
R-HSA-597592 | Post-translational protein modification | 0.660007 | 0.180 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.661960 | 0.179 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.661960 | 0.179 |
R-HSA-5419276 | Mitochondrial translation termination | 0.665013 | 0.177 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.665013 | 0.177 |
R-HSA-73894 | DNA Repair | 0.667677 | 0.175 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.674008 | 0.171 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.674008 | 0.171 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.674816 | 0.171 |
R-HSA-1643685 | Disease | 0.677129 | 0.169 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.679872 | 0.168 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.691286 | 0.160 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.691286 | 0.160 |
R-HSA-373760 | L1CAM interactions | 0.691286 | 0.160 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.696841 | 0.157 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.699581 | 0.155 |
R-HSA-9609646 | HCMV Infection | 0.700880 | 0.154 |
R-HSA-392499 | Metabolism of proteins | 0.703024 | 0.153 |
R-HSA-73886 | Chromosome Maintenance | 0.704987 | 0.152 |
R-HSA-913531 | Interferon Signaling | 0.707515 | 0.150 |
R-HSA-446219 | Synthesis of substrates in N-glycan biosythesis | 0.735455 | 0.133 |
R-HSA-109582 | Hemostasis | 0.736752 | 0.133 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.751763 | 0.124 |
R-HSA-422475 | Axon guidance | 0.753323 | 0.123 |
R-HSA-5368287 | Mitochondrial translation | 0.754010 | 0.123 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.764944 | 0.116 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.764944 | 0.116 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.767072 | 0.115 |
R-HSA-2187338 | Visual phototransduction | 0.775395 | 0.110 |
R-HSA-69242 | S Phase | 0.777429 | 0.109 |
R-HSA-5663205 | Infectious disease | 0.779966 | 0.108 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.781443 | 0.107 |
R-HSA-9609507 | Protein localization | 0.787329 | 0.104 |
R-HSA-69306 | DNA Replication | 0.787329 | 0.104 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.787329 | 0.104 |
R-HSA-9610379 | HCMV Late Events | 0.794933 | 0.100 |
R-HSA-162587 | HIV Life Cycle | 0.794933 | 0.100 |
R-HSA-446193 | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, L... | 0.794933 | 0.100 |
R-HSA-500792 | GPCR ligand binding | 0.802929 | 0.095 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.816845 | 0.088 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.816845 | 0.088 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.827522 | 0.082 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.827522 | 0.082 |
R-HSA-168255 | Influenza Infection | 0.833698 | 0.079 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.838488 | 0.077 |
R-HSA-375276 | Peptide ligand-binding receptors | 0.843981 | 0.074 |
R-HSA-9609690 | HCMV Early Events | 0.857586 | 0.067 |
R-HSA-376176 | Signaling by ROBO receptors | 0.866401 | 0.062 |
R-HSA-9748784 | Drug ADME | 0.884568 | 0.053 |
R-HSA-8951664 | Neddylation | 0.887690 | 0.052 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 0.896563 | 0.047 |
R-HSA-418594 | G alpha (i) signalling events | 0.900226 | 0.046 |
R-HSA-15869 | Metabolism of nucleotides | 0.902087 | 0.045 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.930142 | 0.031 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.930872 | 0.031 |
R-HSA-8957322 | Metabolism of steroids | 0.956331 | 0.019 |
R-HSA-556833 | Metabolism of lipids | 0.966929 | 0.015 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.969792 | 0.013 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.976457 | 0.010 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 0.977311 | 0.010 |
R-HSA-425407 | SLC-mediated transmembrane transport | 0.977932 | 0.010 |
R-HSA-382551 | Transport of small molecules | 0.981819 | 0.008 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.997180 | 0.001 |
R-HSA-1266738 | Developmental Biology | 0.997816 | 0.001 |
R-HSA-9709957 | Sensory Perception | 0.999334 | 0.000 |
R-HSA-1430728 | Metabolism | 0.999983 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK3 |
0.843 | 0.278 | 1 | 0.838 |
COT |
0.835 | 0.075 | 2 | 0.724 |
CAMK2G |
0.832 | 0.246 | 2 | 0.803 |
SRPK1 |
0.831 | 0.198 | -3 | 0.699 |
NLK |
0.830 | 0.221 | 1 | 0.889 |
MTOR |
0.829 | 0.079 | 1 | 0.845 |
DSTYK |
0.826 | 0.050 | 2 | 0.758 |
CDKL1 |
0.824 | 0.098 | -3 | 0.741 |
SRPK2 |
0.824 | 0.164 | -3 | 0.624 |
MST4 |
0.824 | 0.097 | 2 | 0.708 |
PKN3 |
0.822 | 0.069 | -3 | 0.767 |
WNK1 |
0.822 | 0.103 | -2 | 0.778 |
CAMK2D |
0.821 | 0.178 | -3 | 0.776 |
GCN2 |
0.821 | -0.063 | 2 | 0.705 |
PDHK4 |
0.821 | -0.037 | 1 | 0.853 |
IKKB |
0.820 | 0.002 | -2 | 0.680 |
TBK1 |
0.820 | 0.036 | 1 | 0.787 |
NDR2 |
0.820 | 0.076 | -3 | 0.761 |
CDK8 |
0.820 | 0.199 | 1 | 0.791 |
PRKD1 |
0.820 | 0.094 | -3 | 0.767 |
CDK13 |
0.820 | 0.237 | 1 | 0.779 |
CDC7 |
0.820 | -0.021 | 1 | 0.760 |
RAF1 |
0.820 | -0.014 | 1 | 0.833 |
MOS |
0.819 | 0.038 | 1 | 0.800 |
CAMK2A |
0.819 | 0.230 | 2 | 0.829 |
PRPK |
0.819 | -0.058 | -1 | 0.798 |
SRPK3 |
0.819 | 0.161 | -3 | 0.668 |
CAMK2B |
0.819 | 0.217 | 2 | 0.798 |
LATS2 |
0.818 | 0.143 | -5 | 0.785 |
PRKD2 |
0.818 | 0.095 | -3 | 0.708 |
ERK5 |
0.818 | 0.103 | 1 | 0.784 |
NEK6 |
0.818 | 0.012 | -2 | 0.768 |
ULK2 |
0.818 | -0.058 | 2 | 0.640 |
CAMK1B |
0.817 | 0.010 | -3 | 0.783 |
ICK |
0.817 | 0.137 | -3 | 0.769 |
HIPK4 |
0.817 | 0.125 | 1 | 0.844 |
PIM3 |
0.817 | 0.028 | -3 | 0.753 |
IKKE |
0.817 | 0.031 | 1 | 0.782 |
DYRK2 |
0.817 | 0.219 | 1 | 0.813 |
CDKL5 |
0.816 | 0.070 | -3 | 0.738 |
CHAK2 |
0.816 | 0.065 | -1 | 0.897 |
GRK1 |
0.816 | 0.094 | -2 | 0.730 |
CDK19 |
0.815 | 0.190 | 1 | 0.763 |
JNK2 |
0.815 | 0.250 | 1 | 0.763 |
RSK2 |
0.815 | 0.052 | -3 | 0.711 |
BMPR2 |
0.815 | -0.026 | -2 | 0.813 |
PKCD |
0.814 | 0.085 | 2 | 0.671 |
CLK2 |
0.814 | 0.192 | -3 | 0.680 |
CDK5 |
0.814 | 0.225 | 1 | 0.793 |
CDK1 |
0.814 | 0.223 | 1 | 0.747 |
JNK3 |
0.814 | 0.238 | 1 | 0.787 |
PIM1 |
0.814 | 0.090 | -3 | 0.703 |
PDHK1 |
0.814 | -0.058 | 1 | 0.852 |
PRP4 |
0.814 | 0.403 | -3 | 0.932 |
NEK7 |
0.814 | -0.072 | -3 | 0.779 |
KIS |
0.814 | 0.126 | 1 | 0.807 |
BCKDK |
0.814 | 0.006 | -1 | 0.795 |
CDK12 |
0.813 | 0.238 | 1 | 0.764 |
NUAK2 |
0.813 | 0.023 | -3 | 0.756 |
ATR |
0.813 | -0.010 | 1 | 0.794 |
PKN2 |
0.813 | 0.027 | -3 | 0.767 |
FAM20C |
0.813 | 0.059 | 2 | 0.562 |
MAPKAPK2 |
0.813 | 0.088 | -3 | 0.651 |
CLK1 |
0.812 | 0.146 | -3 | 0.681 |
MAPKAPK3 |
0.812 | 0.044 | -3 | 0.707 |
NIK |
0.812 | 0.014 | -3 | 0.802 |
CLK4 |
0.811 | 0.129 | -3 | 0.704 |
DNAPK |
0.811 | 0.174 | 1 | 0.762 |
GRK6 |
0.811 | 0.073 | 1 | 0.775 |
NDR1 |
0.811 | 0.010 | -3 | 0.758 |
CDK18 |
0.811 | 0.222 | 1 | 0.730 |
MNK2 |
0.810 | 0.078 | -2 | 0.696 |
CDK7 |
0.810 | 0.178 | 1 | 0.791 |
RIPK3 |
0.809 | -0.030 | 3 | 0.663 |
P90RSK |
0.809 | 0.022 | -3 | 0.724 |
MLK1 |
0.809 | -0.052 | 2 | 0.673 |
ULK1 |
0.809 | -0.100 | -3 | 0.759 |
IKKA |
0.809 | 0.033 | -2 | 0.675 |
CDK9 |
0.808 | 0.199 | 1 | 0.787 |
ATM |
0.808 | 0.039 | 1 | 0.745 |
CDK3 |
0.808 | 0.225 | 1 | 0.703 |
HIPK2 |
0.807 | 0.214 | 1 | 0.751 |
TGFBR2 |
0.807 | -0.038 | -2 | 0.739 |
GRK5 |
0.807 | -0.070 | -3 | 0.767 |
PKACG |
0.806 | 0.026 | -2 | 0.645 |
WNK3 |
0.806 | -0.107 | 1 | 0.804 |
MARK4 |
0.806 | -0.033 | 4 | 0.792 |
SKMLCK |
0.806 | 0.010 | -2 | 0.760 |
NEK9 |
0.806 | -0.045 | 2 | 0.690 |
ERK1 |
0.805 | 0.207 | 1 | 0.748 |
CDK2 |
0.805 | 0.161 | 1 | 0.797 |
P38A |
0.805 | 0.210 | 1 | 0.793 |
RSK3 |
0.805 | 0.002 | -3 | 0.705 |
CAMLCK |
0.805 | -0.027 | -2 | 0.763 |
P70S6KB |
0.805 | -0.002 | -3 | 0.727 |
HUNK |
0.804 | -0.108 | 2 | 0.628 |
PKR |
0.804 | 0.135 | 1 | 0.793 |
HIPK1 |
0.804 | 0.193 | 1 | 0.822 |
P38G |
0.804 | 0.221 | 1 | 0.688 |
PKCA |
0.804 | 0.058 | 2 | 0.614 |
MNK1 |
0.804 | 0.065 | -2 | 0.711 |
TSSK2 |
0.804 | 0.040 | -5 | 0.900 |
IRE1 |
0.803 | 0.013 | 1 | 0.743 |
AMPKA1 |
0.803 | -0.019 | -3 | 0.777 |
PKCG |
0.803 | 0.034 | 2 | 0.618 |
MSK2 |
0.803 | 0.017 | -3 | 0.682 |
MLK3 |
0.803 | 0.015 | 2 | 0.626 |
LATS1 |
0.803 | 0.072 | -3 | 0.777 |
DAPK2 |
0.802 | -0.045 | -3 | 0.799 |
ERK2 |
0.802 | 0.190 | 1 | 0.783 |
AURC |
0.802 | 0.036 | -2 | 0.584 |
DLK |
0.802 | -0.054 | 1 | 0.794 |
NEK2 |
0.802 | 0.018 | 2 | 0.670 |
P38B |
0.802 | 0.217 | 1 | 0.742 |
PKCB |
0.802 | 0.033 | 2 | 0.620 |
TSSK1 |
0.801 | 0.026 | -3 | 0.799 |
GRK7 |
0.801 | 0.084 | 1 | 0.732 |
RIPK1 |
0.801 | -0.068 | 1 | 0.783 |
PRKD3 |
0.801 | 0.031 | -3 | 0.683 |
RSK4 |
0.801 | 0.054 | -3 | 0.677 |
TTBK2 |
0.801 | -0.103 | 2 | 0.566 |
PRKX |
0.801 | 0.109 | -3 | 0.611 |
CDK17 |
0.801 | 0.194 | 1 | 0.693 |
DYRK4 |
0.800 | 0.203 | 1 | 0.760 |
CDK10 |
0.800 | 0.217 | 1 | 0.760 |
CDK16 |
0.799 | 0.221 | 1 | 0.708 |
AMPKA2 |
0.799 | -0.011 | -3 | 0.745 |
DYRK1A |
0.799 | 0.149 | 1 | 0.841 |
MSK1 |
0.799 | 0.050 | -3 | 0.682 |
ANKRD3 |
0.799 | -0.098 | 1 | 0.825 |
PLK1 |
0.798 | -0.021 | -2 | 0.726 |
NUAK1 |
0.798 | -0.017 | -3 | 0.711 |
PKCH |
0.798 | 0.010 | 2 | 0.601 |
PKCZ |
0.798 | 0.038 | 2 | 0.645 |
ALK4 |
0.798 | 0.010 | -2 | 0.773 |
PAK1 |
0.798 | -0.020 | -2 | 0.693 |
DYRK3 |
0.798 | 0.168 | 1 | 0.825 |
PKACB |
0.797 | 0.053 | -2 | 0.584 |
TGFBR1 |
0.797 | 0.049 | -2 | 0.747 |
PHKG1 |
0.797 | -0.022 | -3 | 0.753 |
PAK6 |
0.797 | 0.003 | -2 | 0.631 |
NIM1 |
0.796 | -0.090 | 3 | 0.693 |
HIPK3 |
0.796 | 0.156 | 1 | 0.834 |
ALK2 |
0.796 | 0.084 | -2 | 0.756 |
MLK2 |
0.796 | -0.093 | 2 | 0.668 |
CDK14 |
0.796 | 0.184 | 1 | 0.774 |
GRK4 |
0.796 | -0.099 | -2 | 0.746 |
DYRK1B |
0.796 | 0.179 | 1 | 0.776 |
P38D |
0.795 | 0.219 | 1 | 0.713 |
CHAK1 |
0.795 | -0.033 | 2 | 0.602 |
ERK7 |
0.795 | 0.138 | 2 | 0.522 |
PLK3 |
0.795 | 0.010 | 2 | 0.684 |
MASTL |
0.795 | -0.234 | -2 | 0.734 |
CAMK4 |
0.795 | -0.079 | -3 | 0.737 |
YSK4 |
0.795 | -0.031 | 1 | 0.782 |
SGK3 |
0.794 | 0.025 | -3 | 0.704 |
IRE2 |
0.794 | -0.020 | 2 | 0.620 |
MLK4 |
0.794 | -0.034 | 2 | 0.605 |
BMPR1B |
0.794 | 0.032 | 1 | 0.681 |
PAK3 |
0.793 | -0.063 | -2 | 0.690 |
AURB |
0.793 | 0.010 | -2 | 0.578 |
AKT2 |
0.793 | 0.026 | -3 | 0.632 |
SMG1 |
0.792 | -0.019 | 1 | 0.755 |
VRK2 |
0.791 | -0.082 | 1 | 0.851 |
MAPKAPK5 |
0.791 | -0.037 | -3 | 0.674 |
MELK |
0.791 | -0.051 | -3 | 0.740 |
AURA |
0.791 | 0.008 | -2 | 0.557 |
QIK |
0.791 | -0.092 | -3 | 0.763 |
GSK3A |
0.791 | 0.117 | 4 | 0.475 |
JNK1 |
0.790 | 0.193 | 1 | 0.742 |
CHK1 |
0.790 | 0.020 | -3 | 0.727 |
CDK4 |
0.790 | 0.221 | 1 | 0.753 |
CAMK1G |
0.790 | -0.014 | -3 | 0.697 |
QSK |
0.790 | -0.046 | 4 | 0.759 |
TLK2 |
0.790 | -0.017 | 1 | 0.782 |
CDK6 |
0.790 | 0.215 | 1 | 0.761 |
MYLK4 |
0.789 | -0.026 | -2 | 0.675 |
PHKG2 |
0.789 | 0.009 | -3 | 0.728 |
PKG2 |
0.789 | -0.000 | -2 | 0.593 |
SIK |
0.789 | -0.048 | -3 | 0.686 |
AKT1 |
0.788 | 0.044 | -3 | 0.648 |
WNK4 |
0.788 | -0.024 | -2 | 0.771 |
HRI |
0.788 | -0.081 | -2 | 0.773 |
ACVR2A |
0.788 | -0.013 | -2 | 0.740 |
DCAMKL1 |
0.788 | -0.002 | -3 | 0.712 |
TAO3 |
0.788 | 0.061 | 1 | 0.795 |
MEK1 |
0.787 | -0.161 | 2 | 0.682 |
PINK1 |
0.787 | -0.042 | 1 | 0.817 |
PLK4 |
0.787 | -0.069 | 2 | 0.482 |
ACVR2B |
0.787 | -0.017 | -2 | 0.746 |
MST3 |
0.787 | 0.038 | 2 | 0.681 |
BRAF |
0.787 | 0.002 | -4 | 0.836 |
PIM2 |
0.787 | 0.017 | -3 | 0.683 |
MAK |
0.787 | 0.184 | -2 | 0.717 |
PKCI |
0.786 | 0.040 | 2 | 0.623 |
PKCT |
0.786 | 0.006 | 2 | 0.607 |
MARK3 |
0.786 | -0.046 | 4 | 0.726 |
PERK |
0.786 | -0.087 | -2 | 0.782 |
MEKK1 |
0.786 | -0.036 | 1 | 0.804 |
MEKK3 |
0.785 | -0.079 | 1 | 0.789 |
PAK2 |
0.785 | -0.074 | -2 | 0.677 |
BRSK1 |
0.785 | -0.066 | -3 | 0.722 |
TLK1 |
0.785 | -0.045 | -2 | 0.748 |
PKACA |
0.784 | 0.031 | -2 | 0.549 |
CK2A2 |
0.784 | 0.162 | 1 | 0.575 |
PKCE |
0.784 | 0.054 | 2 | 0.602 |
MARK2 |
0.784 | -0.056 | 4 | 0.692 |
ZAK |
0.784 | -0.071 | 1 | 0.773 |
BRSK2 |
0.783 | -0.093 | -3 | 0.749 |
IRAK4 |
0.783 | -0.023 | 1 | 0.756 |
NEK5 |
0.783 | -0.018 | 1 | 0.792 |
DCAMKL2 |
0.782 | -0.024 | -3 | 0.728 |
MEKK2 |
0.782 | -0.042 | 2 | 0.659 |
PASK |
0.782 | 0.043 | -3 | 0.770 |
DRAK1 |
0.782 | -0.110 | 1 | 0.691 |
TAO2 |
0.781 | 0.040 | 2 | 0.710 |
MEK5 |
0.781 | -0.155 | 2 | 0.668 |
TTBK1 |
0.781 | -0.098 | 2 | 0.499 |
TNIK |
0.781 | 0.120 | 3 | 0.835 |
CAMKK1 |
0.780 | 0.006 | -2 | 0.734 |
SMMLCK |
0.780 | -0.026 | -3 | 0.752 |
GSK3B |
0.780 | 0.019 | 4 | 0.461 |
GCK |
0.780 | 0.111 | 1 | 0.801 |
HGK |
0.780 | 0.102 | 3 | 0.832 |
CAMK1D |
0.779 | 0.010 | -3 | 0.619 |
MARK1 |
0.779 | -0.078 | 4 | 0.745 |
LKB1 |
0.779 | 0.098 | -3 | 0.827 |
P70S6K |
0.779 | -0.029 | -3 | 0.654 |
PKN1 |
0.778 | 0.015 | -3 | 0.671 |
SNRK |
0.778 | -0.191 | 2 | 0.547 |
SSTK |
0.778 | -0.027 | 4 | 0.746 |
CK1E |
0.778 | -0.067 | -3 | 0.458 |
MOK |
0.778 | 0.152 | 1 | 0.784 |
EEF2K |
0.778 | 0.063 | 3 | 0.837 |
CAMKK2 |
0.777 | 0.019 | -2 | 0.739 |
MINK |
0.777 | 0.091 | 1 | 0.799 |
MPSK1 |
0.777 | 0.004 | 1 | 0.742 |
KHS2 |
0.777 | 0.165 | 1 | 0.814 |
BMPR1A |
0.777 | 0.005 | 1 | 0.669 |
PAK5 |
0.776 | -0.032 | -2 | 0.567 |
NEK8 |
0.776 | -0.078 | 2 | 0.674 |
HPK1 |
0.775 | 0.079 | 1 | 0.801 |
CK2A1 |
0.775 | 0.141 | 1 | 0.550 |
GRK2 |
0.774 | -0.111 | -2 | 0.643 |
NEK11 |
0.774 | -0.102 | 1 | 0.805 |
KHS1 |
0.774 | 0.130 | 1 | 0.810 |
PDK1 |
0.774 | -0.020 | 1 | 0.811 |
NEK4 |
0.773 | -0.022 | 1 | 0.790 |
LRRK2 |
0.772 | 0.015 | 2 | 0.708 |
GAK |
0.772 | 0.004 | 1 | 0.766 |
AKT3 |
0.772 | 0.025 | -3 | 0.577 |
MST2 |
0.772 | -0.025 | 1 | 0.804 |
PAK4 |
0.771 | -0.042 | -2 | 0.578 |
CHK2 |
0.770 | 0.007 | -3 | 0.582 |
TAK1 |
0.770 | -0.010 | 1 | 0.810 |
SGK1 |
0.770 | 0.021 | -3 | 0.558 |
NEK1 |
0.770 | 0.024 | 1 | 0.775 |
SLK |
0.770 | 0.023 | -2 | 0.644 |
LOK |
0.770 | 0.006 | -2 | 0.694 |
MAP3K15 |
0.769 | -0.036 | 1 | 0.775 |
SBK |
0.769 | 0.053 | -3 | 0.520 |
CK1G1 |
0.769 | -0.082 | -3 | 0.455 |
PLK2 |
0.768 | -0.014 | -3 | 0.659 |
STK33 |
0.768 | -0.069 | 2 | 0.495 |
IRAK1 |
0.768 | -0.191 | -1 | 0.735 |
MST1 |
0.767 | 0.003 | 1 | 0.792 |
CK1D |
0.767 | -0.062 | -3 | 0.412 |
CAMK1A |
0.767 | 0.002 | -3 | 0.591 |
MRCKB |
0.767 | 0.019 | -3 | 0.676 |
DAPK3 |
0.766 | -0.026 | -3 | 0.725 |
MRCKA |
0.766 | 0.018 | -3 | 0.686 |
YSK1 |
0.766 | 0.011 | 2 | 0.671 |
MEKK6 |
0.765 | -0.082 | 1 | 0.766 |
CK1A2 |
0.764 | -0.073 | -3 | 0.410 |
HASPIN |
0.764 | 0.053 | -1 | 0.728 |
ROCK2 |
0.761 | 0.021 | -3 | 0.720 |
BUB1 |
0.761 | 0.044 | -5 | 0.835 |
GRK3 |
0.760 | -0.106 | -2 | 0.600 |
DAPK1 |
0.760 | -0.045 | -3 | 0.715 |
VRK1 |
0.759 | -0.129 | 2 | 0.664 |
DMPK1 |
0.758 | 0.046 | -3 | 0.685 |
PDHK3_TYR |
0.758 | 0.272 | 4 | 0.862 |
NEK3 |
0.756 | -0.059 | 1 | 0.769 |
TAO1 |
0.756 | 0.038 | 1 | 0.761 |
RIPK2 |
0.756 | -0.196 | 1 | 0.759 |
MYO3B |
0.755 | 0.053 | 2 | 0.680 |
MEK2 |
0.753 | -0.197 | 2 | 0.646 |
ROCK1 |
0.753 | 0.011 | -3 | 0.691 |
PBK |
0.752 | -0.055 | 1 | 0.691 |
OSR1 |
0.751 | -0.049 | 2 | 0.645 |
PKG1 |
0.751 | -0.039 | -2 | 0.529 |
CRIK |
0.750 | 0.009 | -3 | 0.642 |
MYO3A |
0.749 | -0.005 | 1 | 0.792 |
ASK1 |
0.749 | -0.037 | 1 | 0.769 |
BIKE |
0.748 | 0.013 | 1 | 0.656 |
PDHK4_TYR |
0.748 | 0.125 | 2 | 0.763 |
TESK1_TYR |
0.746 | 0.013 | 3 | 0.803 |
YANK3 |
0.746 | -0.071 | 2 | 0.342 |
TTK |
0.746 | -0.050 | -2 | 0.741 |
ALPHAK3 |
0.744 | -0.046 | -1 | 0.741 |
MAP2K7_TYR |
0.744 | -0.021 | 2 | 0.725 |
BMPR2_TYR |
0.743 | 0.011 | -1 | 0.828 |
MAP2K6_TYR |
0.742 | -0.005 | -1 | 0.836 |
PINK1_TYR |
0.741 | -0.079 | 1 | 0.805 |
MAP2K4_TYR |
0.741 | -0.068 | -1 | 0.813 |
LIMK2_TYR |
0.740 | 0.013 | -3 | 0.826 |
PKMYT1_TYR |
0.739 | -0.090 | 3 | 0.763 |
PDHK1_TYR |
0.739 | -0.004 | -1 | 0.836 |
EPHA6 |
0.736 | -0.013 | -1 | 0.812 |
TYK2 |
0.734 | -0.107 | 1 | 0.804 |
LIMK1_TYR |
0.734 | -0.103 | 2 | 0.705 |
MST1R |
0.732 | -0.093 | 3 | 0.719 |
STLK3 |
0.732 | -0.139 | 1 | 0.755 |
RET |
0.732 | -0.114 | 1 | 0.801 |
AAK1 |
0.732 | 0.036 | 1 | 0.557 |
JAK2 |
0.729 | -0.111 | 1 | 0.804 |
CK1A |
0.728 | -0.097 | -3 | 0.325 |
JAK3 |
0.727 | -0.083 | 1 | 0.778 |
ROS1 |
0.727 | -0.138 | 3 | 0.708 |
DDR1 |
0.727 | -0.146 | 4 | 0.785 |
EPHB4 |
0.726 | -0.113 | -1 | 0.790 |
NEK10_TYR |
0.726 | -0.036 | 1 | 0.716 |
TNNI3K_TYR |
0.726 | -0.004 | 1 | 0.786 |
EPHA4 |
0.725 | -0.037 | 2 | 0.677 |
CSF1R |
0.725 | -0.112 | 3 | 0.699 |
TYRO3 |
0.723 | -0.178 | 3 | 0.724 |
WEE1_TYR |
0.722 | -0.034 | -1 | 0.710 |
INSRR |
0.721 | -0.111 | 3 | 0.669 |
FLT3 |
0.721 | -0.121 | 3 | 0.720 |
FGFR2 |
0.720 | -0.130 | 3 | 0.690 |
JAK1 |
0.719 | -0.080 | 1 | 0.783 |
TNK1 |
0.719 | -0.089 | 3 | 0.699 |
PDGFRB |
0.717 | -0.173 | 3 | 0.716 |
FER |
0.717 | -0.168 | 1 | 0.773 |
KDR |
0.717 | -0.129 | 3 | 0.655 |
EPHB1 |
0.716 | -0.134 | 1 | 0.766 |
TNK2 |
0.716 | -0.136 | 3 | 0.652 |
ABL2 |
0.716 | -0.142 | -1 | 0.738 |
EPHB3 |
0.716 | -0.112 | -1 | 0.774 |
KIT |
0.716 | -0.141 | 3 | 0.694 |
TEK |
0.715 | -0.157 | 3 | 0.656 |
SRMS |
0.715 | -0.131 | 1 | 0.757 |
EPHB2 |
0.715 | -0.114 | -1 | 0.767 |
HCK |
0.714 | -0.159 | -1 | 0.720 |
ITK |
0.714 | -0.137 | -1 | 0.720 |
EPHA3 |
0.714 | -0.093 | 2 | 0.653 |
PDGFRA |
0.714 | -0.183 | 3 | 0.715 |
EPHA7 |
0.713 | -0.085 | 2 | 0.666 |
FGFR1 |
0.713 | -0.165 | 3 | 0.668 |
TXK |
0.713 | -0.094 | 1 | 0.705 |
CK1G3 |
0.712 | -0.079 | -3 | 0.280 |
YANK2 |
0.712 | -0.092 | 2 | 0.361 |
FLT1 |
0.712 | -0.095 | -1 | 0.790 |
LCK |
0.712 | -0.108 | -1 | 0.723 |
YES1 |
0.712 | -0.179 | -1 | 0.728 |
BTK |
0.711 | -0.178 | -1 | 0.679 |
ABL1 |
0.711 | -0.166 | -1 | 0.721 |
ERBB2 |
0.709 | -0.142 | 1 | 0.749 |
BLK |
0.709 | -0.106 | -1 | 0.734 |
FGR |
0.709 | -0.241 | 1 | 0.747 |
BMX |
0.709 | -0.112 | -1 | 0.653 |
FGFR3 |
0.709 | -0.142 | 3 | 0.662 |
MET |
0.708 | -0.153 | 3 | 0.676 |
AXL |
0.708 | -0.186 | 3 | 0.672 |
NTRK1 |
0.708 | -0.184 | -1 | 0.756 |
TEC |
0.707 | -0.140 | -1 | 0.641 |
EPHA1 |
0.707 | -0.131 | 3 | 0.663 |
FLT4 |
0.707 | -0.177 | 3 | 0.650 |
EPHA5 |
0.706 | -0.071 | 2 | 0.666 |
FRK |
0.706 | -0.130 | -1 | 0.749 |
DDR2 |
0.705 | -0.094 | 3 | 0.642 |
INSR |
0.705 | -0.173 | 3 | 0.657 |
MERTK |
0.705 | -0.180 | 3 | 0.663 |
ALK |
0.704 | -0.203 | 3 | 0.631 |
LTK |
0.704 | -0.178 | 3 | 0.638 |
EGFR |
0.704 | -0.075 | 1 | 0.659 |
PTK6 |
0.704 | -0.226 | -1 | 0.643 |
EPHA8 |
0.703 | -0.099 | -1 | 0.760 |
NTRK2 |
0.703 | -0.203 | 3 | 0.654 |
FYN |
0.700 | -0.125 | -1 | 0.683 |
CSK |
0.700 | -0.131 | 2 | 0.664 |
MATK |
0.699 | -0.142 | -1 | 0.698 |
NTRK3 |
0.699 | -0.161 | -1 | 0.713 |
FGFR4 |
0.697 | -0.103 | -1 | 0.709 |
LYN |
0.697 | -0.179 | 3 | 0.634 |
PTK2 |
0.696 | -0.069 | -1 | 0.735 |
SYK |
0.695 | -0.071 | -1 | 0.720 |
MUSK |
0.693 | -0.135 | 1 | 0.644 |
EPHA2 |
0.691 | -0.106 | -1 | 0.735 |
PTK2B |
0.691 | -0.180 | -1 | 0.672 |
IGF1R |
0.690 | -0.160 | 3 | 0.592 |
CK1G2 |
0.690 | -0.106 | -3 | 0.373 |
SRC |
0.688 | -0.193 | -1 | 0.675 |
ERBB4 |
0.686 | -0.096 | 1 | 0.655 |
FES |
0.672 | -0.184 | -1 | 0.617 |
ZAP70 |
0.664 | -0.114 | -1 | 0.673 |